Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

xQUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended December 31, 2020June 30, 2021

¨TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________________ to __________________

Commission File Number: 000-51378

TechPrecision Corporation

(Exact name of registrant as specified in its charter)

Delaware
51-0539828

Delaware

51-0539828

(State or other jurisdiction of

(I.R.S. Employer

incorporation or organization)

Identification No.)

1 Bella Drive

Westminster, MA

01473

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code

(978)

(978) 874-0591

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

N/A

N/A

N/A

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

x
Yes
¨

Yes

No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

x
Yes
¨

Yes

No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

¨

Accelerated filer

¨

Non-accelerated filer

x

Smaller reporting company

x

Emerging growth company

¨

☐ 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act.    ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

¨
Yes
x

Yes

No

The number of shares outstanding of the registrant’s common stock as of February 8,August 6, 2021 was 29,498,662.

Table of Contents

TABLE OF CONTENTS

Page
PART I.

FINANCIAL INFORMATION3

Page

PART I.

FINANCIAL INFORMATION

3

ITEM 1.

FINANCIAL STATEMENTS (UNAUDITED)

3

CONDENSED CONSOLIDATED BALANCE SHEETS

3

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) INCOME

4

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY

5

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

6

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

7

ITEM 2.

MANAGEMENT'SMANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

15

16

ITEM 3.

QUANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK

22

23

ITEM 4.

CONTROLS AND PROCEDURES

22

23

PART II.

OTHER INFORMATION

23

25

ITEM 6.

EXHIBITS

EXHIBITS

25

SIGNATURES

SIGNATURES25

26


2

Table of Contents

PART I

ITEM 1. FINANCIAL STATEMENTS

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)

  

December 31,

2020

  

March 31,

2020

 
ASSETS        
Current assets:        
Cash and cash equivalents $1,255,320  $930,856 
Accounts receivable, net  1,173,376   990,300 
Contract assets  5,314,653   4,504,621 
Raw materials  503,636   561,572 
Work-in-process  694,848   656,041 
Other current assets  442,024   606,151 
Total current assets  9,383,857   8,249,541 
Property, plant and equipment, net  4,208,329   4,182,861 
Deferred income taxes  2,016,816   2,115,480 
Other noncurrent assets, net  16,086   32,600 
Total assets $15,625,088  $14,580,482 
         
LIABILITIES AND STOCKHOLDERS’ EQUITY:        
Current liabilities:        
Accounts payable $510,434  $185,065 
Accrued expenses  1,306,109   1,554,524 
Contract liabilities  308,358   805,049 
Current portion of long-term debt  3,088,553   109,829 
Total current liabilities  5,213,454   2,654,467 
Long-term debt  717,559   2,456,560 
Commitments and contingent liabilities (Note 13)        
Stockholders’ Equity:        

Common stock - par value $.0001 per share, 90,000,000 shares authorized, 29,498,662 and 29,354,594 shares issued and outstanding, at December 31, 2020 and March 31, 2020

  2,949   2,935 
Additional paid in capital  8,911,160   8,793,062 
Accumulated other comprehensive income  21,838   21,688 
Retained earnings  758,128   651,770 
Total stockholders’ equity  9,694,075   9,469,455 
Total liabilities and stockholders’ equity $15,625,088  $14,580,482 

    

June 30, 

    

March 31, 

2021

2021

ASSETS

 

  

Current assets:

 

  

 

  

Cash and cash equivalents

$

2,236,375

$

2,130,711

Accounts receivable

 

1,155,403

 

608,059

Contract assets

 

4,815,808

 

5,532,408

Raw materials

472,486

503,636

Work-in-process

559,658

767,520

Other current assets

 

375,830

 

379,437

Total current assets

 

9,615,560

 

9,921,771

Property, plant and equipment, net

 

3,884,729

 

4,063,209

Deferred income taxes

 

1,907,835

 

1,934,415

Other noncurrent assets, net

 

82,596

 

84,624

Total assets

$

15,490,720

$

16,004,019

LIABILITIES AND STOCKHOLDERS’ EQUITY:

 

  

 

  

Current liabilities:

 

  

 

  

Accounts payable

$

169,769

$

500,848

Accrued expenses

 

1,066,671

 

1,526,270

Contract liabilities

 

428,367

 

218,152

Current portion of long-term debt

 

2,449,979

 

2,474,963

Total current liabilities

 

4,114,786

 

4,720,233

Long-term debt, net

 

29,452

 

1,341,938

Commitments and contingent liabilities (Note 14)

 

  

 

  

Stockholders’ Equity:

 

  

 

  

Common stock - par value $.0001 per share, 90,000,000 shares authorized, 29,498,662 shares issued and outstanding, at June 30, 2021 and March 31, 2021

 

2,949

 

2,949

Additional paid in capital

 

8,978,160

 

8,944,660

Accumulated other comprehensive income

 

21,880

 

21,838

Retained earnings

 

2,343,493

 

972,401

Total stockholders’ equity

 

11,346,482

 

9,941,848

Total liabilities and stockholders’ equity

$

15,490,720

$

16,004,019

See accompanying notes to the condensed consolidated financial statements.


3

Table of Contents

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME (LOSS) INCOME (unaudited)

  Three Months Ended
December 31,
  Nine Months Ended
December 31,
 
  2020  2019  2020  2019 
Net sales $3,569,718  $3,667,276  $11,566,176  $11,075,620 
Cost of sales  2,864,274   3,352,962   9,034,858   9,238,287 
Gross profit  705,444   314,314   2,531,318   1,837,333 
Selling, general and administrative  716,361   662,675   2,205,739   2,145,055 
(Loss) income from operations  (10,917)  (348,361)  325,579   (307,722)
Other (expense) income  (219)  185   1,237   21,063 
Interest expense  (50,405)  (69,328)  (159,885)  (218,447)
Total other expense, net  (50,624)  (69,143)  (158,648)  (197,384)
(Loss) income before income taxes  (61,541)  (417,504)  166,931   (505,106)
Income tax (benefit) expense  (13,369)  (97,734)  60,573   (115,092)
Net (loss) income $(48,172) $(319,770) $106,358  $(390,014)
Other comprehensive income (loss), before tax:                
Foreign currency translation adjustments $1,252  $9  $151  $(329)
Other comprehensive income (loss), net of tax $1,252  $9  $151  $(329)
Comprehensive (loss) income $(46,920) $(319,761) $106,509  $(390,343)
Net (loss) income per share basic $(0.00) $(0.01) $0.00  $(0.01)
Net (loss) income per share diluted $(0.00) $(0.01) $0.00  $(0.01)
Weighted average number of shares outstanding: Basic  29,498,662   29,254,594   29,430,206   29,254,230 
Diluted  29,498,662   29,254,594   31,021,384   29,254,230 

Three months ended

June 30, 

    

2021

    

2020

Net sales

$

3,412,229

$

3,282,525

Cost of sales

 

2,579,561

 

2,585,511

Gross profit

 

832,668

 

697,014

Selling, general and administrative

 

732,608

 

793,362

Income (loss) from operations

 

100,060

 

(96,348)

Other income

 

10,390

 

652

Interest expense

 

(29,878)

 

(57,898)

PPP loan forgiveness

1,317,100

Total other income (expense), net

 

1,297,612

 

(57,246)

Income (loss) before income taxes

 

1,397,672

 

(153,594)

Income tax provision (benefit)

 

26,580

 

(37,360)

Net income (loss)

$

1,371,092

$

(116,234)

Other comprehensive income (loss):

 

 

Foreign currency translation adjustments

42

(97)

Other comprehensive income (loss), net of tax

42

(97)

Comprehensive income (loss)

$

1,371,134

$

(116,331)

Net income (loss) per share - basic

$

0.05

$

(0.01)

Net income (loss) per share - diluted

$

0.04

$

(0.01)

Weighted average number of shares outstanding - basic

29,498,662

29,359,921

Weighted average number of shares outstanding – diluted

31,054,110

29,359,921

See accompanying notes to the condensed consolidated financial statements.


4

Table of Contents

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (unaudited)

  

Common

Stock
Outstanding

  

Par

Value

  

Additional
Paid in

Capital

  

Accumulated

Other
Comprehensive
Income

  

 

Retained
Earnings

  

Total
Stockholders’
Equity

 
Balance 3/31/2019  29,234,594  $2,923  $8,693,106  $21,940  $993,339  $9,711,308 
Stock-based compensation          30,625           30,625 
Shares issued under LTIP  20,000   2   7,198           7,200 
Net income                  220,777   220,777 
Currency translation adjustment              (179)      (179)
Balance 6/30/2019  29,254,594  $2,925  $8,730,929  $21,761  $1,214,116  $9,969,731 
Stock-based compensation          30,625           30,625 
Net loss                  (291,021)  (291,021)
Currency translation adjustment              (159)      (159)
Balance 9/30/2019  29,254,594  $2,925  $8,761,554  $21,602  $923,095  $9,709,176 
Stock-based compensation          20,417           20,417 
Net loss                  (319,770)  (319,770)
Currency translation adjustment              9       9 
Balance 12/31/2019  29,254,594  $2,925  $8,781,971  $21,611  $603,325  $9,409,832 
                         
Balance 3/31/2020  29,354,594  $2,935  $8,793,062  $21,688  $651,770  $9,469,455 
Stock-based compensation          55,500           55,500 
Shares issued under LTIP  44,068   4   (4)          -- 
Net loss                  (116,234)  (116,234)
Currency translation adjustment              (97)      (97)
Balance 6/30/2020  29,398,662  $2,939  $8,848,558  $21,591  $535,536  $9,408,624 
Stock-based compensation          57,417           57,417 
Restricted stock award  100,000   10   133,990           134,000 
Non-vested restricted stock          (134,000)          (134,000)
Net income                  270,764   270,764 
Currency translation adjustment              (1,005)      (1,005)
Balance 9/30/2020  29,498,662  $2,949  $8,905,965  $20,586  $806,300  $9,735,800 
Stock-based compensation          33,500           33,500 
Taxes on exercised options          (28,305)          (28,305)
Net loss                  (48,172)  (48,172)
Currency translation adjustment              1,252       1,252 
Balance 12/31/2020  29,498,662  $2,949  $8,911,160  $21,838  $758,128  $9,694,075 

    

    

    

    

Accumulated

    

    

Common

Additional

Other

Total

Stock

Par

Paid in

Comprehensive

Retained

Stockholders’

Outstanding

Value

Capital

Income

Earnings

Equity

Balance 3/31/2020

    

29,354,594

    

$

2,935

    

$

8,793,062

    

$

21,688

    

$

651,770

    

$

9,469,455

Stock-based compensation

55,500

55,500

Shares issued under LTIP

 

44,068

 

4

 

(4)

 

 

Net loss

 

 

 

(116,234)

 

(116,234)

Foreign currency translation adjustment

 

 

 

(97)

 

(97)

Balance 6/30/2020

 

29,398,662

$

2,939

$

8,848,558

$

21,591

$

535,536

$

9,408,624

Balance 3/31/2021

 

29,498,662

$

2,949

$

8,944,660

$

21,838

$

972,401

$

9,941,848

Stock-based compensation

33,500

33,500

Net income

 

 

 

 

 

1,371,092

 

1,371,092

Foreign currency translation adjustment

 

 

 

 

42

 

 

42

Balance 6/30/2021

 

29,498,662

$

2,949

$

8,978,160

$

21,880

$

2,343,493

$

11,346,482


See accompanying notes to the condensed consolidated financial statements.


5

Table of Contents

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)

  Nine Months Ended December 31, 
  2020  2019 
CASH FLOWS FROM OPERATING ACTIVITIES        
Net income (loss) $106,358  $(390,014)
Adjustments to reconcile net income (loss) to net cash (used in) provided by operating activities:        
Depreciation  521,422   548,038 
Amortization of debt issue costs  45,099   31,280 
Stock based compensation expense  146,417   81,667 
Change in contract loss provision  (175,365)  216,039 
Deferred income taxes  60,573   (115,092)
Changes in operating assets and liabilities:        
Accounts receivable  (183,076)  257,459 
Contract assets  (810,032)  (271,767)
Inventories  19,129   589,904 
Other current assets  164,127   (296,328)
Other noncurrent assets  38,092   (9,419)
Accounts payable  325,369   (138,463)
Accrued expenses  (101,028)  18,282 
Contract liabilities  (496,691)  87,815 
Net cash (used in) provided by operating activities  (339,606)  609,401 
CASH FLOWS FROM INVESTING ACTIVITIES        
Purchases of property, plant and equipment  (546,890)  (35,225)
Net cash used in investing activities  (546,890)  (35,225)
CASH FLOWS FROM FINANCING ACTIVITIES        
Debt issue costs  (24,610)  (32,209)
Proceeds from payroll protection program loan  1,317,100   -- 
Proceeds from revolver loan  1,000,000   -- 
Repayment of revolver loan  (1,000,000)  -- 
Repayment of long-term debt  (81,352)  (610,515)
Net cash provided by (used in) financing activities  1,211,138   (642,724)
Effect of exchange rate on cash and cash equivalents  (178)  307 
Net increase (decrease) in cash and cash equivalents  324,464   (68,241)
Cash and cash equivalents, beginning of period  930,856   2,036,646 
Cash and cash equivalents, end of period $1,255,320  $1,968,405 
SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION        
Cash paid during the year for:        
Interest (net of amounts capitalized) $106,342  $187,085 
Income taxes $--  $-- 

Three Months Ended June 30, 

    

2021

    

2020

CASH FLOWS FROM OPERATING ACTIVITIES

  

  

Net income (loss)

$

1,371,092

$

(116,234)

Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:

 

 

Depreciation

 

182,678

 

169,237

Amortization of debt issue costs

 

8,824

 

15,141

Stock based compensation expense

 

33,500

 

55,500

Change in contract loss provision

 

(69,951)

 

(64,699)

Deferred income taxes

 

26,580

 

(37,360)

PPP loan forgiveness

(1,317,100)

Changes in operating assets and liabilities:

 

 

Accounts receivable

 

(547,344)

 

73,771

Contract assets

 

716,600

 

(692,842)

Inventories

239,012

(79,834)

Other current assets

 

3,607

 

187,261

Accounts payable

 

(331,079)

 

370,914

Accrued expenses

 

(389,586)

 

38,614

Contract liabilities

 

210,215

 

(288,712)

Net cash provided by (used in) operating activities

 

137,048

 

(369,243)

CASH FLOWS FROM INVESTING ACTIVITIES

 

 

Purchases of property, plant and equipment

 

(4,198)

 

(41,768)

Net cash used in investing activities

 

(4,198)

 

(41,768)

CASH FLOWS FROM FINANCING ACTIVITIES

 

 

Debt issue costs

 

 

(8,282)

Proceeds from payroll protection program

 

 

1,317,100

Proceeds from revolver loan

1,000,000

Repayment of revolver loan

 

 

(1,000,000)

Repayment of long-term debt

(27,166)

(26,618)

Net cash (used in) provided by financing activities

 

(27,166)

 

1,282,200

Effect of exchange rate on cash and cash equivalents

 

(20)

 

(6)

Net increase in cash and cash equivalents

 

105,664

 

871,183

Cash and cash equivalents, beginning of period

 

2,130,711

 

930,856

Cash and cash equivalents, end of period

$

2,236,375

$

1,802,039

SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION

 

 

Cash paid during the year for:

Interest

$

32,746

$

40,024

Income taxes

$

$

See accompanying notes to the condensed consolidated financial statements.

SUPPLEMENTAL INFORMATION - NONCASH INVESTING AND FINANCING TRANSACTIONS:

NineThree months ended December 31,June 30, 2020

On June 16,13, 2020, our executive officers exercised options to purchase 150,000 shares of the Company’s common stock, par value $0.0001 per share, in a cashless transaction, pursuant to option awards granted under the Company’s 2016 Long-Term Incentive Plan.


6

Table of Contents

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (unaudited)

NOTE 1 - DESCRIPTION OF BUSINESS

TechPrecision Corporation, or TechPrecision, is a Delaware corporation organized in February 2005 under the name Lounsberry Holdings II, Inc. The name was changed to TechPrecision Corporation on March 6, 2006. TechPrecision is the parent company of Ranor, Inc., or Ranor, a Delaware corporation, Stadco New Acquisition, LLC, and Wuxi Critical Mechanical Components Co., Ltd., or WCMC, a wholly foreign owned enterprise. WCMC has no customers or operations, and we have initiated a plan of termination to legally dissolve this subsidiary. TechPrecision, WCMC, Stadco New Acquisition, LLC, and Ranor are collectively referred to as the “Company”, “we”, “us” or “our”.

We manufacture large-scale metal fabricated and machined precision components and equipment. These products are used in a variety of markets including defense and aerospace, nuclear, medical, and precision industrial. We consider our business to consist of one segment - metal fabrication and precision machining. All of our operations and customers are located in the United States.

NOTE 2 - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

Basis of Presentation and Consolidation - The accompanying condensed consolidated financial statements include the accounts of TechPrecision, Ranor, Stadco New Acquisition, LLC, and WCMC. Intercompany transactions and balances have been eliminated in consolidation. The accompanying condensed consolidated balance sheets as of December 31, 2020June 30, 2021 and March 31, 2020,2021, the condensed consolidated statements of operations and comprehensive income (loss) income and stockholders’ equity for the three and nine months ended December 31,June 30, 2021 and 2020, and 2019, and the condensed consolidated statements of cash flows for the ninethree months ended December 31,June 30, 2021 and 2020 and 2019 are unaudited, but, in the opinion of management, include all adjustments that are necessary for a fair presentation of our financial statements for interim periods in accordance with U.S. Generally Accepted Accounting Principles, or U.S. GAAP. All adjustments are of a normal, recurring nature, except as otherwise disclosed. The results of operations for an interim period are not necessarily indicative of the results of operations to be expected for the fiscal year.

These notes to the condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission, or the SEC, for Quarterly Reports on Form 10-Q. Certain information and disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. These unaudited financial statements and related notes should be read in conjunction with the consolidated financial statements included with our Annual Report on Form 10-K for the fiscal year ended March 31, 2020,2021, or the 20202021 Form 10-K, filed with the SEC on June 11, 2020.10, 2021.

Use of Estimates in the Preparation of Financial Statements -In preparing the condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and revenues and expenses during the reported period. We continually evaluate our estimates, including those related to contract accounting, accounts receivable, inventories, the recovery of long-lived assets, income taxes and the valuation of equity transactions. We base our estimates on historical and current experiences and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ from those estimates.

The COVID-19 pandemic has negatively affected certain customers, suppliers and their labor force. For example, travel restrictions in connection with the pandemic have delayed inspections, deliveries and impacted some supply chain providers. The future financial impact of the COVID-19 pandemic cannot be reasonably estimated at this time as its impact depends on future developments, which are highly uncertain and cannot be predicted.

The directives imposed by federal, state and local governments as a result of the COVID-19 pandemic did not impair our ability to maintain operations during the first nine months of fiscal 2021 as the Company was designated an essential service. Our estimates at the end of the first nine months of fiscal 2021 assumed no material impact from the disruptions caused by COVID-19.

NOTE 3 - ACCOUNTING STANDARDS UPDATE

New Accounting Standards Recently Adopted

On April 1, 2020 we adopted ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement.  This ASU modifies the disclosure requirements in Topic 820 by removing, modifying or adding certain disclosures.  The amendments for changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty are applied prospectively.  All other amendments are applied retrospectively to all periods presented upon their effective date.  The adoption did not have a significant impact on our consolidated financial statement disclosures.


Issued Standards Not Yet Adopted

In December, 2019, the Financial Accounting Standards Board (FASB)(“FASB”) issued ASUAccounting Standards Update (“ASU”) No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, expected to reduce cost and complexity related to the accounting for income taxes. This ASU removes specific exceptions to the general principles in Topic 740 under U.S. GAAP and removes the limitation on the tax benefit recognized on pre-tax losses in interim periods. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. The

7

Table of Contents

Company plans to adopt the standardadopted ASU 2019-12 on April 1, 2021 and is currently evaluating the amendments in this update to determine thedid not have a significant impact it may have on itsour financial statements and disclosures.

NOTE 4 - REVENUE

The Company generates its revenuesrevenue primarily from performance obligations completed under contracts with customers in two main market sectors: defense and precision industrial. The period over which the Company performs its obligations can range from be between three to and thirty-six months. The Company invoices and receives related payments based upon performance progress not less frequently than monthly.

Revenue is recognized over-time or at a point-in-time given the terms and conditions of the related contracts. The Company utilizes an inputs methodology based on estimated labor hours to measure performance progress. This model best depicts the transfer of control to the customer.

The Company’s contract portfolio is comprised of fixed-price contracts and providesprovide for product type sales only. The following table presents net sales on a disaggregated basis by market and contract type:

Net Sales by market Defense  Industrial  Totals 
Three months ended December 31, 2020 $2,885,753  $683,965  $3,569,718 
Three months ended December 31, 2019 $3,200,671  $466,605  $3,667,276 
Nine months ended December 31, 2020 $9,314,846  $2,251,330  $11,566,176 
Nine months ended December 31, 2019 $9,725,635  $1,349,985  $11,075,620 
             
Net Sales by contract type Over-time  Point-in-time   Totals 
Three months ended December 31, 2020 $3,141,416  $428,302  $3,569,718 
Three months ended December 31, 2019 $3,439,367  $227,909  $3,667,276 
Nine months ended December 31, 2020 $9,251,284  $2,314,892  $11,566,176 
Nine months ended December 31, 2019 $9,104,395  $1,971,225  $11,075,620 

Net Sales by market

    

Defense

    

Industrial

    

Totals

Three months ended June 30, 2021

$

3,103,132

$

309,097

$

3,412,229

Three months ended June 30, 2020

$

3,203,590

$

78,935

$

3,282,525

Net Sales by contract type

    

Over-time

    

Point-in-time

    

Totals

Three months ended June 30, 2021

$

3,122,649

$

289,580

$

3,412,229

Three months ended June 30, 2020

$

3,027,897

$

254,628

$

3,282,525

As of December 31, 2020,June 30, 2021, the Company had $18.4$17.6 million of remaining performance obligations, of which $13.0 million were less than 50% complete. The Company expects to recognize all of its remaining performance obligations as revenue over-time or at a point-in-time duringwithin the next thirty-six months.

We have beenare dependent in each year on a small number of customers who generate a significant portion of our business, and these customers can change from year to year. The following table presentssets forth revenues from customers who accounted for more than 10% or more of our net sales for the following periods:three months ended:

  Three months ended
December 31, 2020
  Three months ended
December 31, 2019
  Nine months ended
December 31, 2020
  Nine months ended
December 31, 2019
 
Customer Amount  Percent  Amount  Percent  Amount  Percent  Amount  Percent 
A $398,011   11% $404,062   11% $2,106,998   18% $1,790,311   16%
B $530,583   15% $*   *% $1,871,256   16% $*   *%
C $609,114   17% $1,215,737   33% $1,679,814   15% $2,320,485   21%
D $682,337   19% $727,084   20% $1,631,010   14% $1,825,213   16%
E $550,096   15% $*   *% $*   *% $*   *%
F $*   *% $*   *% $*   *% $1,136,146   10%
G $*   *% $*   *% $*   *% $1,148,242   10%

June 30, 2021

June 30, 2020

Customer

    

Amount

    

Percent

    

Amount

    

Percent

    

A

$

1,303,772

38

%  

$

570,780

17

%  

B

$

*

 

*

%  

$

1,014,655

 

31

%  

C

$

938,856

 

28

%  

$

654,187

 

20

%  

D

$

*

 

*

%  

$

390,512

 

12

%  

*Less than 10% of total


OnIn our condensed consolidated balance sheet, contract assets and contract liabilities are reported in a net position on a contract-by-contract basis at the end of each reporting period. In fiscalFor the three months ended June 30, 2021, we recognized revenue of $0.8less than $0.1 million related to our contract liabilities at March 31, 2020. At December 31, 2020 contractApril 1, 2021. Contract assets consisted of the following:following at:

Contract assets Unbilled  Less:Progress 
payments
  Total 
December 31, 2020 $10,074,902  $4,760,249  $5,314,653 
March 31, 2020 $10,635,588  $6,130,967  $4,504,621 

Progress

    

Unbilled

    

payments

    

Total

June 30, 2021

$

8,638,677

$

(3,822,869)

$

4,815,808

March 31, 2021

$

11,392,948

$

(5,860,540)

$

5,532,408

8

Table of Contents

NOTE 5 - INCOME TAXES

We accountThe Company accounts for income taxes under the provisions of FASB ASC 740, Income Taxes.Taxes. The tax provision for interim periods is determined using the estimated annual effective consolidated tax rate, based on the current estimate of full-year earnings before taxes, adjusted for the impact of discrete quarterly items. The income tax provision for income taxes was $26,580 for the ninethree months ended December 31, 2020 was $60,573,June 30, 2021 and the income tax benefit was $37,360 for the ninethree months ended December 31, 2019 was $115,092.June 30, 2020. The Company's estimatedCompany’s effective tax rate for the ninethree months ended December 31, 2020June 30, 2021 was 36.3%.

approximately 2%, due to the nontaxable PPP loan forgiveness item of $1.3 million disclosed in the condensed consolidated statement of operations.

The valuation allowance on deferred tax assets was approximately $1.7 million at December 31, 2020.June 30, 2021. We believe that it is more likely than not that the benefit from certain state and foreign net operating losses, or NOL, carryforwards and other deferred tax assets will not be realized. In the event future taxable income is below management’s estimates or is generated in tax jurisdictions different than projected, the Company could be required to increase the valuation allowance for deferred tax assets. This would result in an increase in the Company’s effective tax rate.

NOTE 6 - EARNINGS PER SHARE

Basic earnings per shareEPS is computed by dividing reported earnings available to stockholders by the weighted average number of shares outstanding. Diluted earnings per shareEPS also includes the effect of stock options that would be dilutive. The following table provides a reconciliation of the numerators and denominators reflected in the basic and diluted earnings per share computations as required under FASB ASC 260.for the three months ended:

  Three months ended
December 31, 2020
  Three months ended
December 31, 2019
  Nine months ended
December 31, 2020
  Nine months ended
December 31, 2019
 
Basic EPS:                
Net (loss) income $(48,172) $(319,770) $106,358  $(390,014)
Weighted average shares  29,498,662   29,254,594   29,430,206   29,254,230 
Basic (loss) income per share $(0.00) $(0.01) $0.00  $(0.01)
Diluted EPS:                
Net (loss) income $(48,172) $(319,770) $106,358  $(390,014)
Dilutive effect of stock options  --   --   1,591,178   -- 
Diluted weighted average shares  29,498,662   29,254,594   31,021,384   29,254,230 
Diluted (loss) income per share $(0.00) $(0.01) $0.00  $(0.01)

    

June 30, 2021

    

June 30, 2020

Basic EPS

  

  

Net income (loss)

$

1,371,092

$

(116,234)

Weighted average shares

 

29,498,662

 

29,359,921

Net income (loss) per share

$

0.05

$

(0.01)

Diluted EPS

 

 

Net income (loss)

$

1,371,092

$

(116,234)

Dilutive effect of stock options

 

1,555,448

 

Weighted average shares

 

31,054,110

 

29,359,921

Net income (loss) per share

$

0.04

$

(0.01)

All potential common stock equivalents that have an anti-dilutive effect (i.e. those that increase income per share or decrease loss per share) are excluded from the calculation of diluted earnings per share.EPS. For the three months ended December 31,June 30, 2020, there were 2,814,0002,816,000 of potentially anti-dilutive stock options, none of which were included in the EPS calculations above. For the nine months ended December 31, 2020, there were 94,000 of common stock equivalents that were out-of-the-money and not included in the above earnings per share calculations. For the three and nine months ended December 31, 2019, there were 2,967,000 of potentially anti-dilutive stock options, none of which were included in the EPS calculations above.

NOTE 7 - STOCK-BASED COMPENSATION

Our board of directors, upon the recommendation of the compensation committee of our board of directors, approved the 2016 TechPrecision Equity Incentive Plan, or the 2016 Plan, on November 10, 2016. Our stockholders approved the 2016 Plan at the Company’s Annual Meeting of Stockholders on December 8, 2016. The 2016 Plan succeeds the 2006 Plan and applies to awards granted after the 2016 Plan’s adoption by the Company’s stockholders. We have designed the 2016 Plan to reflect our commitment to having best practices in both compensation and corporate governance. The 2016 Plan provides for a share reserve of 5,000,000 shares of common stock.

The 2016 Plan authorizes the award of incentive and non-qualified stock options, restricted stock awards, restricted stock units, and performance awards to employees, directors, consultants, and other individuals who provide services to TechPrecision or its affiliates. The purpose of the 2016 Plan is to: (a) enable TechPrecision and its affiliated companies to recruit and retain highly qualified employees, directors and consultants; (b) provide those employees, directors and consultants with an incentive for productivity; and (c) provide those employees, directors and consultants with an opportunity to share in the growth and value of the Company. Subject to adjustment as provided in the 2016 Plan, the maximum number of shares of common stock that may be issued with respect to awards under the 2016 Plan is 5,000,000

9


Table of Contents

shares (inclusive of awards issued under the 2006 Long-Term Incentive Plan, or the 2006 Plan, that remained outstanding as of the effective date of the 2016 Plan). Shares of our common stock subject to awards that expire unexercised or are otherwise forfeited shall again be available for awards under the 2016 Plan.

At December 31, 2020June 30, 2021, there were 1,376,0001,470,000 shares available for grant under the 2016 Plan. The following table summarizes information about stock option activity:options granted during the most recently completed periods:

 Number Of  

Weighted

Average

 

Aggregate
Intrinsic

 

Weighted
Average
Remaining
Contractual Life

 
 Options  Exercise Price  Value  (in years) 
Outstanding at 3/31/2019  2,938,000  $0.416  $1,869,200   6.74 

Weighted

Average

Weighted

Aggregate

Remaining

Number Of

Average

Intrinsic

Contractual Life

    

Options

    

Exercise Price

    

Value

    

(in years)

Outstanding at 3/31/2020

2,916,000

$

0.415

$

2,546,800

6.21

Exercised  (20,000)  0.360         

(150,000)

0.800

Canceled  (2,000)            

 

(47,000)

 

Outstanding at 3/31/2020  2,916,000  $0.415  $2,546,800   6.21 

Outstanding at 3/31/2021

2,719,000

$

0.372

$

2,476,300

5.62

Canceled  (2,000)            

(49,000)

Exercised  (150,000)  0.800         
Outstanding at 12/31/2020  2,764,000  $0.393  $2,743,300   5.81 
Vested or expected to vest at 12/31/2020  2,764,000  $0.393  $2,743,300   5.81 
Exercisable and vested at 12/31/2020  2,764,000  $0.393  $2,743,300   5.81 

Vested or expected to vest at 6/30/2021

 

2,670,000

$

0.343

$

2,422,900

5.39

Exercisable and vested at 6/30/2021

2,670,000

$

0.343

$

2,422,900

5.39

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the closing stock price on the last trading day of the thirdfirst quarter of fiscal 20212022 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on December 31, 2020.June 30,2021. This amount changes based on the fair market value of the Company’s common stock.

At December 31, 2020,June 30,2021, there was no0 remaining unrecognized compensation cost related to stock options. The maximum contractual term is ten years for option grants. Other information relating to stock options outstanding at December 31, 2020June 30,2021 is as follows:

Weighted

Average

Remaining

Weighted

Weighted

Options

Contractual

Average

Options

Average

Range of Exercise Prices: 

Options
Outstanding

  

Weighted
Average
Remaining

Contractual
Term

  

Weighted
Average
Exercise Price

  

Options
Exercisable

  

Weighted
Average
Exercise Price

 

    

Outstanding

    

Term 

    

Exercise Price

    

Exercisable

    

Exercise Price

$0.01-$1.00  2,670,000   5.87  $0.34   2,670,000  $0.34 
$1.01-$1.96  94,000   0.26  $1.84   94,000  $1.84 

$0.01‑$0.49

1,270,000

4.35

$

0.12

1,270,000

$

0.12

$0.50‑$0.99

 

1,400,000

 

5.90

$

0.55

 

1,400,000

$

0.55

Totals  2,764,000           2,764,000     

 

2,670,000

 

 

 

2,670,000

 

Restricted Stock Awards

On September 1, 2020 we granted a total of 100,000 shares of restricted stock under the 2016 Plan to the board of directors. The stock-based compensation expense of $134,000 for service-based restricted stock was measured at fair value on the date of grant based on the number of shares expected to vest and the quoted market price of the Company’s common stock. The shares of restricted stock fully vest and cease to be subject to forfeiture on August 31, 2021, or twelve months following the grant date. Each grantee must be serving as a director on the vesting date and must have been continuously serving in such capacity from the grant date through the vesting date for the shares of restricted stock to vest. Prior to the vesting date, the grantee is not permitted to sell, transfer, pledge, assign or otherwise encumber the shares of restricted stock and if the grantee’s service with the Company terminates prior to the vesting date, the grantee’s restricted stock will be forfeited automatically. Total recognized compensation cost related to the restricted stock award was $44,667 for the ninethree months ended December 31, 2020.June 30, 2021 was $33,500. At December 31, 2020June 30, 2021 there was $89,333$22,333 of unrecognized compensation cost related to these restricted stock awards.

On March 16, 2020 we granted a total10

Table of 100,000 shares of restricted stock under the 2016 Plan to the board of directors. The stock-based compensation expense of $111,000 for service-based restricted stock was measured at fair value on the date of grant based on the number of shares expected to vest and the quoted market price of the Company’s common stock. The shares of restricted stock fully vested and ceased to be subject to forfeiture on September 1, 2020, or approximately six months following the grant date. Each grantee must have been serving as a director on the vesting date and must have been continuously serving in such capacity from the grant date through the vesting date for the shares of restricted stock to vest. Prior to the vesting date, the grantee was not permitted to sell, transfer, pledge, assign or otherwise encumber the shares of restricted stock and if the grantee’s service with the Company had terminated prior to the vesting date, the grantee’s restricted stock would have been forfeited automatically. Total recognized compensation cost related to the restricted stock award was $101,750 for the nine months ended December 31, 2020. There was no unrecognized compensation cost related to these restricted stock awards at December 31, 2020.Contents


NOTE 8 - CONCENTRATION OF CREDIT RISK

We maintain bank account balances, which, at times, may exceed insured limits. We have not experienced any losses with these accounts and believe that we are not exposed to any significant credit risk on cash.

At December 31, 2020,June 30, 2021, there were trade accounts receivable balances outstanding from five3 customers comprising 93%75% of the total trade receivables balance. The following table sets forth information as to trade accounts receivable from customers who accounted for more than 10% of the totalour accounts receivable balance at:as of:

  December 31, 2020  March 31, 2020 
Customer Dollars  Percent  Dollars  Percent 
A $356,228   30% $*  * 
B $243,938   21% $*  * 
C $193,750   17% $*  * 
D $*   *  $365,636  37%
E $167,152   14% $254,637  26%
F $*     *  $123,000  12%
G $123,909   11% $*  * 

 *less

June 30, 2021

March 31, 2021

 

Customer

    

Dollars

    

Percent

    

Dollars

    

Percent

 

A

$

503,250

44

%  

$

*

*

%

B

$

*

 

*

%  

$

399,692

 

66

%

C

$

*

 

*

%  

$

193,368

 

32

%

D

$

222,982

19

%

$

*

*

%

E

$

135,300

12

%

$

*

*

%

*

less than 10% of total

NOTE 9 - OTHER CURRENT ASSETS

 December 31, 2020  March 31, 2020 

Other current assets included the following as of:

    

June 30, 2021

    

March 31, 2021

Payments advanced to suppliers $31,268  $272,070 

$

18,918

$

17,010

Prepaid insurance  358,029   250,073 

 

210,146

 

312,669

Prepaid subscriptions  22,057   14,440 

 

40,395

 

25,967

Refundable AMT credits  22,748   22,748 
Employee advances  --   18,173 

 

29,419

 

16,526

Deposits

72,400

Other  7,922   28,647 

 

4,552

 

7,265

Total $442,024  $606,151 

$

375,830

$

379,437

NOTE 10 - PROPERTY, PLANT AND EQUIPMENT, NET

Property, plant and equipment, net included the following as of:

    

June 30, 2021

    

March 31, 2021

Land

$

110,113

$

110,113

Building and improvements

 

3,249,577

 

3,249,577

Machinery equipment, furniture and fixtures

 

10,699,776

 

10,695,578

Equipment under finance leases

 

45,663

 

45,663

Total property, plant and equipment

 

14,105,129

 

14,100,931

Less: accumulated depreciation

 

(10,220,400

)

 

(10,037,722)

Total property, plant and equipment, net

$

3,884,729

$

4,063,209

NOTE 1011 - ACCRUED EXPENSES

 December 31, 2020  March 31, 2020 

Accrued expenses included the following as of:

    

June 30, 2021

    

March 31, 2021

Accrued compensation

$

542,455

$

496,320

Provision for claims settlement $495,000  $495,000 

495,000

Accrued compensation  316,490   383,555 
Provision for contract losses  110,115   285,480 

 

94,213

 

164,164

Accrued professional fees  244,703   279,657 

 

284,477

 

213,213

Accrued project costs  109,062   76,059 

 

95,675

 

114,611

Other  30,739   34,773 

 

49,851

 

42,962

Total $1,306,109  $1,554,524 

$

1,066,671

$

1,526,270

Accrued compensation includes amounts for executive bonuses, payroll and vacation and holiday pay. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in the

11

Table of Contents

provision are recorded in cost of sales. Accrued project costs are estimates for certain project expenses during the reporting period.

NOTE 11 -12 – DEBT

Total debt included the following as of: December 31, 2020  March 31, 2020 

Long-term debt included the following as of:

    

June 30, 2021

    

March 31, 2021

Berkshire Term Loan at 5.21% interest, due December 2021 $2,491,835  $2,564,389 

$

2,441,355

$

2,466,408

Berkshire SBA PPP loan at 1% interest, due May 2022  1,317,100   -- 

 

 

1,317,100

Finance lease obligations at 8% interest, due January 2022  13,662   22,460 

Obligations under finance lease

 

43,550

 

45,663

Total debt $3,822,597  $2,586,849 

$

2,484,905

$

3,829,171

Less: debt issue costs unamortized $16,485  $20,460 

$

5,474

$

12,270

Total debt, net $3,806,112  $2,566,389 

$

2,479,431

$

3,816,901

Less: Current portion of long-term debt $3,088,553  $109,829 

$

2,449,979

$

2,474,963

Total long-term debt, net $717,559  $2,456,560 

$

29,452

$

1,341,938

Small Business Administration Loan

On May 8, 2020, the Company, through its wholly owned subsidiary Ranor, issued a promissory note, or the Note, evidencing an unsecured loan in the amount of $1,317,100 made to Ranor under the Paycheck Protection Program, or the PPP. The PPP was established under the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, and is administered by the U.S. Small Business Administration, or the SBA. The loan to Ranor was made through Berkshire Bank.

Principal and accrued interest are payable monthly in equal installments commencing at a future date in calendar year 2021 and continuing through the maturity date, unless the Note is forgiven as described below. To be available for loan forgiveness, the Note may only be used for payroll costs, costs related to certain group health care benefits and insurance premiums, rent payments, utility payments, mortgage interest payments and interest payments on any other debt obligations that existed before February 15, 2020. The Note may be prepaid at any time prior to maturity with no prepayment penalties and contains events of default and other conditions customary for a Note of this type. For example, the Note contains events of default relating to, among other things, payment defaults, making materially false and misleading representations to the SBA or Berkshire Bank or breaching the terms of the loan documents. The occurrence of an event of default may result in the repayment of all amounts outstanding, collection of all amounts owing from the Company, or the SBA or Berkshire Bank filing suit and obtaining judgment against the Company and/or Ranor.

Under the terms of the CARES Act, PPP loan recipients can apply for and be granted forgiveness for all or a portion of loan granted under the PPP, with such forgiveness to be determined, subject to limitations, based on the use of the loan proceeds for payment of payroll costs, certain group health care benefits and insurance premiums, and any payments of mortgage interest, rent, and utilities. The terms of any forgiveness may also be subject to further requirements in any regulations and guidelines the SBA may adopt. While the Company currently believes that its use of the Note proceeds will meet the conditions for forgiveness under the PPP, no assurance is provided that the Company will obtain forgiveness of the Note in whole or in part.

On June 5, 2020, the PPP was amended to give borrowers more time to spend loan proceeds and still obtain loan forgiveness. The amendments extended the length of the covered period as defined in the CARES Act from eight to twenty-four weeks, while allowing borrowers that received PPP loans before June 5, 2020 to elect to use the original eight-week covered period. In addition, the amendments provide that if the borrower does not apply for forgiveness of a loan within ten months after the last day of the covered period, the PPP loan is no longer deferred and the borrower must begin paying principal and interest. As provided under the amendments, our first payment, if required, would not be due until September 11, 2021.

Berkshire Term Loan Facility

On December 21, 2016, TechPrecision, through Ranor, closed on a Loan Agreement, or the Berkshire Loan Agreement, with Berkshire Bank. Pursuant to the Berkshire Loan Agreement, Berkshire Bank made a term loan to Ranor in the amount of $2,850,000, or the Term Loan, and made available to Ranor a revolving line of credit in the amount of $1,000,000, underor the Revolver Loan, orand together with the Term Loan, the Berkshire Loans. The Berkshire Loans are secured by a first lien on all personal and real property of Ranor.

Payments on the Term Loan began on January 20, 2017 and will be made in 60 monthly installments of $19,260 each, inclusive of interest at a fixed rate of 5.21% per annum, with all outstanding principal and accrued interest due and payable on the maturity date. A balloon principal payment of approximately $2,400,000 is due on December 20, 2021 under the Term Loan. A prepayment penalty will apply during the loan term but will not apply if a prepayment is made from either casualty loss insurance proceeds or a condemnation award applicable to any collateral or if a full prepayment is made during the 45-day period immediately preceding the maturity date. Advances under the Revolver Loan were originally subject to a borrowing base equal to the lesser of (A) $1,000,000 and (B) the sum of (i) 80% of eligible accounts receivable, and (ii) the lesser of (a) 25% of eligible raw material inventory and (b) $250,000.

On December 23, 2019, TechPrecision, through Ranor, entered into a Third Modification to Loan Agreement, or the Third Modification, and an Amended and Restated Promissory Note with Berkshire Bank. Under the Third Modification, Ranor and Berkshire agreed to increase the maximum principal amount available under the Revolver Loan from $1,000,000 to $3,000,000. Advances under the Revolver Loan are now subject to a borrowing base equal to the lesser of (a) $3,000,000 or (b) the sum of (i) 80% of eligible accounts receivable, plus (ii) the lesser of (x) 25% of Eligible Raw Material Inventory, and (y) $250,000, plus (iii) 50% of the Appraised Value of the Eligible Equipment. The loan agreement is available for refinancing existing indebtedness and for working capital and general corporate purposes. Additionally, the parties agreed to lower the interest rate on advances made under the Revolver Loan at a variable rate equal to the one-month LIBOR plus 225 basis points. The Third Modification contains customary LIBOR replacement provisions.

The Company pays, as consideration for the bank’s commitment to make advances under the Revolver Loan, a nonrefundable commitment fee equal to 0.25% per annum on the average daily difference between the amount of $3,000,000 and the aggregate amount of all advances made under the Revolver Loan as of each quarterly period. The Third Modification also excludes the balance of the Revolver Loan from the Loan-to-Value Ratio covenant calculations.

On December 18, 2020, TechPrecision, through Ranor, entered into a Fourth Modification to Loan Agreement and First Modification and Allonge to Amended and Restated Promissory Note, or the Fourth Modification, with Berkshire Bank. The Modification amends and modifies the Berkshire Loan Agreement. The Fourth Modification also amends the Amended and Restated Promissory Note dated December 23, 2019 made by Ranor in favor of Berkshire in the stated principal amount of $3,000,000. As of the date of the Fourth Modification, there was approximately $2.5 million in remaining principal outstanding under the Term Loan and nowere 0 amounts outstanding under the Revolver Loan.

Under the Fourth Modification, Ranor and Berkshire agreed to revise the minimum interest rate payable on the Revolver Loan. Under the promissory note for the Revolver Loan, the Company can elect to pay interest at an adjusted LIBOR-basedLIBOR-

12

Table of Contents

based rate or an Adjusted Prime Rate. Under the Fourth Modification, the minimum adjusted LIBOR-based rate is 2.75% and the Adjusted Prime Rate is the greater of (i) the Prime Rate minus 70 basis points or (ii) 2.75%. Interest-only payments on advances made under the Revolver Loan will continue to be payable monthly in arrears. The maturity date of the Revolver Loan was also extended to December 20, 2022. All other material terms of the Berkshire Loan Agreement and the promissory note for the Revolver Loan were unchanged.


The Company borrowed $1.0 millionThere were 0 interest payments and no advances made under the Revolver Loan on April 3, 2020 and repaid principal of $1.0 million onduring the three months ended June 30, 2020.2021. Unused borrowing capacity at June 30, 2021 and March 31, 2021 was $3.0 and $2.7 million, respectively. There were no0 borrowed amounts outstanding under the Revolver Loan at December 31, 2020June 30, 2021 and March 31, 2020. Interest payments on advances made2021.

The Berkshire Loans may be accelerated upon the occurrence of an “Event of Default” (as defined in the Berkshire Loan Agreement). Events of Default include (i) the failure to pay any monthly installment payment before the tenth day following the due date of such payment; (ii) the failure of Ranor or TechPrecision to observe, perform or pay any obligations under the RevolverBerkshire Loan duringAgreement or any other obligation to Berkshire; (iii) the nine months endedfailure of Ranor or TechPrecision to pay any indebtedness in excess of $100,000 (other than the Berkshire Loans) when due; (iv) any representation or warranty of Ranor or TechPrecision in the Berkshire Loan Agreement and related documents, or the Loan Documents, being proven to have been incorrect, in any material respect, when made; (v) the failure of Ranor to discharge any attachment, levy or distraint on its property; (vi) any default by Ranor or TechPrecision under any of the collateral security documents executed in connection with the Berkshire Loan Agreement past any applicable grace period; (vii) the failure of Ranor or TechPrecision to file or pay taxes when due, unless such taxes are being contested in a manner permitted under the Loan Documents; (viii) a change in ownership or control of Ranor or change in management of Ranor where either the chief executive officer or chief financial officer as of December 21, 2016 is replaced without Berkshire Bank’s prior consent; (ix) Ranor or TechPrecision ceasing to do business as a going concern, making an assignment for the benefit of creditors, or commencing a bankruptcy or other similar insolvency proceeding; and (x) the entry of a judgment against Ranor or TechPrecision in excess of $150,000. Some of the Events of Default are subject to certain cure periods. Subject to the lapse of any applicable cure period, a default under the Berkshire Loans could cause the acceleration of all outstanding obligations under the Berkshire Loans.

Pursuant to the Berkshire Loan Agreement, the Company covenants to cause its balance sheet leverage to be less than or equal to 2.50 to 1.00 for the fiscal year ending March 31, 2020 were $6,664 at a weighted average interest rate of 2.67%. Unused borrowing capacity at December 31, 2020 was $3.0 million.

2019 and each fiscal year end thereafter. The Berkshire Loan Agreement also contains a covenant whereby the Company is required to maintain a debt service coverage ratio, or DSCR, of at least 1.2 to 1.0 during the term of the Berkshire Loans. The DSCR is measured at the end of each fiscal quarter of the Company. The Company was in compliance with all of the financial covenants at December 31, 2020 and March 31, 2020.

The Berkshire Loan Agreement also contains covenants to cause its balance sheet leverage to be less than or equal to 2.50 to 1.00 for each fiscal year end, and requirean additional covenant whereby Ranor is required to maintain a loan-to-value ratio of not greater than 0.75 to 1.00, to be measured by appraisal not more frequently than one time during each 365-day period.period, and annual capital expenditures cannot exceed $1,500,000. The Company was in compliance with all of the financial covenants at June 30, 2021 and March 31, 2021.

Unamortized debt issue costs at June 30, 2021 and March 31, 2021 were $17,448 and $26,272, respectively.

Finance LeaseCollateral securing the above obligations comprises all personal and real property of TechPrecision and Ranor, including cash, accounts receivable, inventories, equipment, and financial assets.

See Note 12 for information regarding our obligations under the finance lease.

Fair Value Measurements

We account for fair value measurements in accordance with ASC Topic 820, Fair Value Measurement, which defines fair value and establishes a framework to measure fair value and the related disclosures about fair value. The carrying value of short and long-term borrowings approximates their fair value at December 31, 2020 and March 31, 2020. The fair value of the long-term debt was calculated based on interest rates available for debt with terms and maturities similar to the Company's existing debt arrangements.value. The Company’s short-term and long-term debt with Berkshire bank is all privately held with no public market for thethis debt and is considered to be Level 3 under the fair value hierarchy.

Small Business Administration Loan

On May 8, 2020, the Company, through its wholly owned subsidiary Ranor, issued a promissory note, or the Note, evidencing an unsecured loan in the amount of $1,317,100 made to Ranor under the Paycheck Protection Program, or the PPP. The PPP was established under the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act and is administered by the U.S. Small Business Administration, or the SBA. The loan to Ranor was made through Berkshire Bank.

13

Table of Contents

Principal and accrued interest were set to be payable monthly in equal installments commencing in September 2021 and continuing through the maturity date, unless the Note was forgiven as described below.

Under the terms of the CARES Act, PPP loan recipients can apply for and be granted forgiveness for all or a portion of loan granted under the PPP, with such forgiveness to be determined, subject to limitations, based on the use of the loan proceeds for payment of payroll costs, certain group health care benefits and insurance premiums, and any payments of mortgage interest, rent, and utilities.

On June 5, 2020, the PPP was amended to give borrowers more time to spend loan proceeds and still obtain loan forgiveness. The amendments extended the length of the covered period as defined in the CARES Act from eight to twenty-four weeks, while allowing borrowers that received PPP loans before June 5, 2020 to elect to use the original eight-week covered period.

The Company applied for loan forgiveness with the SBA under the Paycheck Protection Program on March 26, 2021. On May 12, 2021, as authorized by Section 1106 of the CARES Act, the SBA remitted to Berkshire Bank, the lender of record, a payment of principal and interest in the amount of $1,317,100 and $13,207, respectively, for forgiveness of the Company’s Paycheck Protection Program (PPP) loan. The funds credited to the bank paid this loan off in full. Loan forgiveness is recorded as a gain under other income and expense in the condensed consolidated statement of operations.

Finance Lease

We leased certain office equipment during fiscal 2021 under an old finance lease that was cancelled in March 2021. We entered into a new finance lease on March 31, 2021 in the amount of $45,663 for certain office equipment. The lease term is for 60 months, bears interest at 3.2% and requires monthly payments of principal and interest of $825. The amount of the lease recorded as a right-of-use asset in property, plant and equipment was $45,663 as of March 31, 2021.

See Note 13 for more information regarding our obligations under the finance lease.

NOTE 1213 – LEASES

Leases that are economically similar to the purchase of an asset are classified as finance leases. The leased, or right-of-use assets in finance lease arrangements are reported in net property, plant and equipment on our condensed consolidated balance sheet. Right-of-useThe following table lists our right-of-use assets and liabilities on our condensed consolidated balance sheet at December 31, 2020 were:at:

    

June 30, 2021

    

March 31, 2021

Finance lease: December 31, 2020 

Property, plant and equipment $54,376 

$

45,663

$

45,663

Accumulated depreciation  43,501 

 

(2,283)

 

Net property, plant and equipment $10,875 

$

43,380

$

45,663

Current portion of long-term debt $12,569 

$

8,624

$

8,555

Long-term debt $1,093 

$

34,926

$

37,108

Total finance lease liabilities $13,662 

$

43,550

$

45,663

In December 2019, we signed a one-year operating lease for office space which expired in December 2020 and was amortized on a straight line basis. Since the expiration of the one-year term of the lease, we have continued to lease this office

14

Table of Contents

space on a month-to-month basis. Other supplemental information regarding our leases are contained in the following tables:

Components of lease expense for the period ended: December 31, 2020 

Components of lease expense for the three months ended:

    

June 30, 2021

    

June 30, 2020

Operating lease amortization $2,878 

$

1,234

$

949

Finance lease amortization $8,156 

$

2,283

$

2,719

Finance lease interest $1,102 

$

362

$

2,674

Weighted average lease term and discount rate at:December 31, 2020
Finance lease term (years)1.25
Finance lease rate8%

Weighted average lease term and discount rate at:

    

June 30, 2021

    

June 30, 2020

Lease term (years)

 

5.00

 

1.75

Lease rate

 

3.2

%

 

8.0

%

Supplemental cash flow information related to leases for the period ended: December 31, 2020 

Supplemental cash flow information related to leases for the three months ended:

    

June 30, 2021

    

June 30, 2020

Cash used in operating activities $2,878 

$

1,596

$

949

Cash used in financing activities $8,798 

$

2,113

$

2,875

NOTE 1314 - COMMITMENTS

Retirement Benefits

Ranor has a defined contribution and savings plan that covers substantially all Ranor employees who have completed 90 days of service. Ranor retains the option to match employee contributions. The Company contributed $21,897$21,388 and $64,167$20,725 for the three and nine months ended December 31, 2020.June 30, 2021 and 2020, respectively.

Provision for claims settlement

On March 16, 2020, the Company reached an agreement to settle all outstanding claims for $495,000 related to a civil action brought by former employees for past wages claimed under a paid time-off program. The claim is to be paid within sixty days following Court approval of the settlement. Such approval has not yet occurred.

NOTE 14 –15 - SUBSEQUENT EVENTS

Securities Purchase Agreement

OnAs previously disclosed, on October 16, 2020, the Company entered into a stock purchase agreement or(as subsequently amended, the SPA,SPA) with Stadco New Acquisition, LLC, a wholly owned subsidiary of the Company, or the Acquisition Sub, Stadco,STADCO, Stadco Acquisition, LLC, or the Target,Holdco, and each stockholder of Target.Holdco. The SPA provides for the Company, through Acquisition Sub, to acquire all of the issued and outstanding capital stock of StadcoSTADCO from Target. Stadco,Holdco. STADCO, the operating subsidiary of Target,Holdco, is a California corporation in the business of manufacturing high-precision parts, assemblies and tooling for aerospace, defense, research and commercial customers. As consideration for the acquisition of all of Target’s common stock, the Company, on behalf of Acquisition Sub, will issue 1,000,000 shares of the Company’s common stock to Target. The Company, Stadco and Target are also working, through negotiation with creditors of Stadco and Target, to substantially reduce the approximately $14 million of Stadco liabilities that would otherwise be added to the consolidated balance of the combined company after closing of the acquisition. Reaching agreements with these creditors to the satisfaction of the Company is required for the closing of the deal to occur. The Company expects that a percentage of these liabilities will be satisfied in part or full through the issuance of additional shares of the Company’s common stock.

The SPA contains customary representations and warranties of Stadco, Target, the Company and Acquisition Sub, and Stadco and Target have agreed to customary covenants relating to the conduct of their business during the interim period between the execution of the SPA and the closing of the acquisition. The consummation of the acquisition and the related transactions contemplated by the SPA is subject to certain customary conditions.

On February 2,July 23, 2021, the Company entered into an amendmentthe Third Amendment to Stock Purchase Agreement effective as of December 15, 2020, to the previously disclosed stock purchase agreement providing for the AcquisitionJuly 20, 2021, with Acquisition Sub, Stadco, TargetSTADCO, Holdco and each stockholderDouglas A. Paletz, as representative of Target.the STADCO stockholders of Holdco. Under the terms of SPA, if the Acquisition was not closed by DecemberJuly 31, 2020,2021, either the Company or Stadco could have terminated the SPA. The Third Amendment effected a change to this provision by extending until February 28,August 31, 2021 the date after which the parties may terminate if the Acquisition has not closed.

The Third Amendment also effected changes to the consideration payable for STADCO’s securities in the Acquisition. Previously, the SPA provided that the consideration payable by the Company for 100% of the shares of common stock of STADCO in the Acquisition would be 1,000,000 shares of the Company’s common stock. Under the Third Amendment, at the closing of the Acquisition, the Company will issue 666,666 shares of the Company’s common stock, or the Consideration Shares, as consideration for 100% of the shares of common stock of STADCO. However, if one year following the closing of the Acquisition, the Company’s stock price does not have an average closing price of at least $1.65 per share, then the Company must (i) issue additional shares to Holdco that have an aggregate market value equal to the difference between the market value of the Consideration Shares and the value of the Consideration Shares if they had traded at $1.65 per share, (ii) pay such difference in cash or (iii) undertake any combination of the foregoing. The Amendment also effected certain other minor changes to the SPA.

15

Loan Purchase and Sale Agreement

On January 29, 2021, in connection with securities purchase agreement described above, Acquisition Sub entered into a Loan Purchase and Sale Agreement, effective January 26, 2021, with Sunflower Bank, N.A., and agreed to by Stadco, Target, and Stadco Mexico, Inc.  Under the termsTable of the Loan Purchase Agreement, Acquisition Sub agreed to purchase certain indebtedness obligations of Stadco consisting of long-term indebtedness and revolving credit line indebtedness owed to Sunflower Bank. The current amount outstanding under these indebtedness obligations is approximately $9.8 million. In exchange, Acquisition Sub agreed to pay $2 million less than the aggregate amount of the indebtedness that is then outstanding on the date of the closing of the transactions contemplated under the Loan Purchase Agreement.  The closing of the indebtedness purchase is subject to the closing of the acquisition contemplated under the SPA and will take place on or about February 15, 2021, with an optional grace period of up to an additional 15 days.  In connection with the closing, Acquisition Sub will also guaranty repayment by Stadco to Sunflower Bank of any of the original approximately $1.5 million in principal indebtedness under Stadco’s Paycheck Protection Program Loan that is not forgiven under the terms of the Coronavirus Aid, Relief, and Economic Security Act.  The Loan Purchase Agreement contains customary representations and warranties of each party, as well as mutual indemnification provisions.Contents


Item 2.

Item 2.Management’s Discussion and Analysis of Financial Condition and Results of Operations

Statement Regarding Forward Looking Disclosure

 

The following discussion of the results of our operations and financial condition should be read in conjunction with our condensed consolidated financial statements and the related notes, which appear elsewhere in this Quarterly Report on Form 10-Q. This Quarterly Report on Form 10-Q, including this section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” may contain predictive or “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of current or historical fact contained in this quarterly report, including statements that express our intentions, plans, objectives, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” “should,” “would” and similar expressions, as they relate to us, are intended to identify forward-looking statements.

These statements are based on current expectations, estimates and projections made by management about our business, our industry and other conditions affecting our financial condition, results of operations or business prospects. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, the forward-looking statements due to numerous risks and uncertainties. Factors that could cause such outcomes and results to differ include, but are not limited to, risks and uncertainties arising from:

our reliance on individual purchase orders, rather than long-term contracts, to generate revenue;
our ability to balance the composition of our revenues and effectively control operating expenses;
external factors, including the COVID-19 pandemic, that may be outside of our control;
the impacts of the COVID-19 pandemic and government-imposed lockdowns in response thereto;
the availability of appropriate financing facilities impacting our operations, financial condition and/or liquidity;
our ability to receive contract awards through competitive bidding processes;
our ability to maintain standards to enable us to manufacture products to exacting specifications;
our ability to enter new markets for our services;
our reliance on a small number of customers for a significant percentage of our business;
competitive pressures in the markets we serve;
changes in the availability or cost of raw materials and energy for our production facilities;
operating in a single geographic location;
restrictions in our ability to operate our business due to our outstanding indebtedness;
government regulations and requirements;
pricing and business development difficulties;
changes in government spending on national defense;
our ability to make acquisitions and successfully integrate those acquisitions with our business;
general industry and market conditions and growth rates;

16

Table of Contents

·our reliance on individual purchase orders, rather than long-term contracts, to generate revenue;
·our ability to balance the composition of our revenues and effectively control operating expenses;
·external factors, including the COVID-19 pandemic, that may be outside of our control;
·the impacts of the COVID-19 pandemic and government-imposed lockdowns in response thereto;
·the availability of appropriate financing facilities impacting our operations, financial condition and/or liquidity;
·our ability to receive contract awards through competitive bidding processes;
·our ability to maintain standards to enable us to manufacture products to exacting specifications;
·our ability to enter new markets for our services;
·our reliance on a small number of customers for a significant percentage of our business;
·competitive pressures in the markets we serve;
·changes in the availability or cost of raw materials and energy for our production facilities;
·operating in a single geographic location;
·restrictions in our ability to operate our business due to our outstanding indebtedness;
·government regulations and requirements;
·pricing and business development difficulties;
·changes in government spending on national defense;
·our ability to make acquisitions and successfully integrate those acquisitions with our business;
·general industry and market conditions and growth rates;
·general economic conditions;
·the risk that the proposed acquisition of Stadco may not be completed in a timely manner or at all, which may adversely affect the Company’s business and the price of Company’s common stock;
·the failure of either party to satisfy any of the conditions to the consummation of the proposed acquisition of Stadco and uncertainties as to the timing of the consummation of the proposed acquisition;
·the occurrence of any event, change or other circumstance that could give rise to the termination of the securities purchase agreement governing the proposed acquisition of Stadco;
·the effect of the announcement or pendency of the proposed acquisition of Stadco on the Company’s business relationships, operating results and business generally;
risks related to diverting management’s attention from the Company’s ongoing business operations;
unexpected costs, charges or expenses resulting from the proposed acquisition of Stadco; and
·risks related to diverting management’s attention from the Company’s ongoing business operations;
·unexpected costs, charges or expenses resulting from the proposed acquisition of Stadco; and
·those risks discussed in Item“Item 1A. Risk FactorsFactors” and elsewhere in our 2020 Annual Report on Form 10-K, as well as those described in any other filings which we make with the SEC.

Any forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to publicly update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this Quarterly Report on Form 10-Q, except as required by applicable law. Investors should evaluate any statements made by us in light of these important factors.

Overview

Contract Manufacturing

We offer a full range of services required to transform raw materials into precision finished products. Our manufacturing capabilities include: fabrication operations (cutting, press and roll forming, assembly, welding, heat treating, blasting and painting) and machining operations including CNC (computer numerical controlled) horizontal and vertical milling centers. We also provide support services to our manufacturing capabilities: manufacturing engineering (planning, fixture and tooling development, manufacturing), quality control (inspection and testing), materials procurement, production control (scheduling, project management and expediting) and final assembly.


All manufacturing is done in accordance with our written quality assurance program, which meets specific national and international codes, standards, and specifications. Ranor holds several certificates of authorization issued by the American Society of Mechanical Engineers and the National Board of Boiler and Pressure Vessel Inspectors. The standards used are specific to the customers’ needs, and our manufacturing operations are conducted in accordance with these standards.

Because our revenues are derived from the sale of goods manufactured pursuant to a contract, and we do not sell from inventory, it is necessary for us to constantly seek new contracts. There may be a time lag between our completion of one contract and commencement of work on another contract. During such periods, we may continue to incur overhead expense but with lower revenue resulting in lower operating margins. Furthermore, changes in either the scope of an existing contract or related delivery schedules may impact the revenue we receive under the contract and the allocation of manpower. Although we provide manufacturing services for large governmental programs, we usually do not work directly for the government or its agencies. Rather, we perform our services for large governmental contractors. Our business is dependent in part on the continuation of governmental programs whichthat require our services and products.

Our contracts are generated both through negotiation with the customer and from bids made pursuant to a request for proposal. Our ability to receive contract awards is dependent upon the contracting party’s perception of such factors as our ability to perform on time, our history of performance, including quality, our financial condition and our ability to price our services competitively.  Although some of our contracts contemplate the manufacture of one or a limited number of units, we continue to seek more long-term projects with predictable cost structures.

17

Table of Contents

Financial Results

Our results of operations are affected by a number of external factors including the availability of raw materials, commodity prices (particularly steel), macroeconomic factors, including the availability of capital that may be needed by our customers, and political, regulatory and legal conditions in the United States and in foreign markets. Generally, our projects are made up of short-term contracts with a production timeline that can range from three to as much as thirty-six months. Units manufactured under the majority of our customer contracts are delivered on time and with a positive gross margin. Our results of operations for any specific period are also affected by our success in booking new contracts, the timing of revenue recognition, delays in customer acceptances of our products, delays in deliveries of ordered products and our rate of progress fulfilling obligations under our contracts. A delay in deliveries or cancellations of orders could have an unfavorable impact on liquidity, cause us to have inventories in excess of our short-term needs, and delay our ability to recognize, or prevent us from recognizing, revenue on contracts in our order backlog.

If revenue for a particular quarter is below our expectations, we may not be able to proportionally reduce operating expenses for that quarter. Therefore, a revenue shortfall would have a disproportionate effect on our operating results for that quarter. We have reported operating losses in four of the last seven quarters. In Fiscal 2020 we reported a loss from operations of $0.1 million, due primarily to an increase in cost of sales for losses on certain customer projects. Until we complete and deliver the final units from these projects, they will continue to dampen gross margin in future quarterly periods.

For the ninethree months ended December 31, 2020, ourJune 30, 2021, we recorded net sales and net income were $11.6of $3.4 million and $0.1$1.4 million, respectively, compared with net sales of $11.1$3.3 million and net loss of $0.4$0.1 million, for the ninethree months ended December 31, 2019.June 30, 2020. Our gross margin for the ninethree months ended December 31, 2020 and 2019June 30, 2021 was 21.9% and 16.6%, respectively. We used $0.3 million24.4% compared with gross margin of cash in operations21.2% for the ninethree months ended December 31, 2020 and had a cash balance of $1.3 million at December 31,June 30, 2020. Our sales order backlog at December 31, 2020 and March 31, 2020 was approximately $18.4 million and $16.8 million, respectively.

Acquisition of Stadco

We recently announced an agreement to purchase a company that manufactures precision parts for the defense and aerospace industries. Incremental costs incurred for due diligenceOn May 12, 2021, as a result of this agreement could impact earnings in future quarterly periods. Becauseauthorized by Section 1106 of the sizeCoronavirus Aid, Relief, and Economic Security Act, or the CARES Act, the Small Business Administration, or the SBA, remitted to Berkshire Bank, the lender of this acquisition target relative to our business, following closing, we expect to report that our resultsrecord, a payment of operations, cash flowsprincipal and financial condition will differ materially from those reported to date. The acquisition agreement is subject to certain conditions, and may or may not be completed unless all of the conditions set forthinterest in the agreement are completed. Failure to successfully integrateamount of $1,317,100 and realize the expected benefits of such acquisitions or to implement our acquisition strategy, including successfully integrating acquired businesses, could have an adverse effect on our business, financial condition and results of operations.


COVID-19

At the end of March 2020, the outbreak of coronavirus (COVID-19) had spread worldwide as a pandemic. The full extent of the outbreak, related business and travel restrictions and changes to social behavior intended to reduce its spread remain uncertain and subject to change as the health crisis continues to evolve in the U.S. and abroad. The directives imposed by federal, state and local governments did not impair our ability to maintain operations during the first nine months of fiscal 2021 as the Company was designated an “Essential Service.” The pandemic has nevertheless negatively affected certain$13,207, respectively, for forgiveness of the Company’s customers, suppliers and labor force, and withPaycheck Protection Program loan or PPP loan. The funds credited to the changing conditionsbank paid this loan off in full. Loan forgiveness is recorded as a result of the COVID-19 outbreak, the impact on our operations and financial results for the remainder of calendar year 2021 remains uncertain.

We and our customers have been designated essential services as national critical infrastructure companies by the U.S. Department of Homeland Security. Additionally, we believe that the long term outlook for the defense industry remains positive as we continue to see meaningful opportunities in our defense sector, primarilygain in the nuclear submarine business for the next twelve months and beyond.condensed consolidated statement of operations.

Critical Accounting Policies

Estimates

The preparation of the condensed consolidated financial statements requires that we make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We base our estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We continually evaluate our estimates, including those related to revenue recognition, inventories, recovery of long-lived assets, income taxes and the valuation of equity transactions. These estimates and assumptions require management'smanagement’s most difficult, subjective or complex judgments. Actual results may differvary under different assumptions or conditions.

We consider the principles and estimates applied for revenue recognition to be one of the most critical accounting estimates that we make. Our revenue can fluctuate from quarter-to-quarter as we measure revenue recognition over the duration of a project, or at the end of the project. The Company records most of its revenue over time as it completes performance obligations or at a point-in-time, for example, at the delivery date, when control of the promised goods are transferred to the customer. Project volume for revenue recognized at a point-in-time is generally smaller, can fluctuate from period to period, and is difficult to forecast.

We measure progress for performance obligations satisfied over time using input methods, for example, labor hours expended and time elapsed. As a result, assuming a steady flow of project volume and labor hours, we have the ability to deliver a fair and accurate flow of revenue over time. When project volume is higher or lower, we may report higher or lower amounts of revenue for those given quarterly periods.

Our significant accounting policies are set forth in detail in Note 2 to the consolidated financial statements included in the 20202021 Annual Report on Form 10-K. We consider the policies relating to revenue recognition to be a critical accounting policy.10-K. There have been no significant changes to our critical accounting policies during the ninethree months ended December 31, 2020.June 30, 2021.

18

Table of Contents

Accounting Pronouncements

New Accounting Standards

See Note 3, Accounting Standards Update, in the Notes to the condensed consolidated financial statements in “Item 1. Financial Statements” for a discussion of recently adopted new accounting guidance and new accounting guidance not yet adopted.

guidance.

Key Performance Indicators

While we prepare our financial statements in accordance with U.S. generally accepted accounting principles, or U.S. GAAP, we also utilize and present certain financial measures that are not based on or included in U.S. GAAP. We refer to these as Non-GAAP financial measures. Please see the section “EBITDA Non-GAAP financial measure” below for further discussion of these financial measures, including the reasons why we use such financial measures and reconciliations of such financial measures to the most directly comparable U.S. GAAP financial measures.

Three Months Ended December 31,June 30, 2021 and 2020 and 2019

The following table sets forth information from our condensed consolidated statements of operations and comprehensive income (loss) income,, in dollars and as a percentage of revenue:

  December 31, 2020  December 31, 2019  Changes 
(dollars in thousands) Amount  Percent  Amount  Percent  Amount  Percent 
Net sales $3,569   100% $3,667   100% $(98)  (3)%
Cost of sales  2,864   80%  3,353   91%  (489)  (15)%
Gross profit  705   20%  314   9%  391   124%
Selling, general and administrative  716   20%  663   18%  53   8%
Loss from operations  (11)  -%  (349)  (9)%  338   97%
Other expense, net  (50)  (1)%  (69)  (2)%  19   28%
Loss before taxes  (61)  (2)%  (418)  (11)%  357   85%
Income tax benefit  (13)  (1)%  (98)  (3)%  85   87%
Net loss $(48)  (1)% $(320)  (8)% $272   85%

June 30, 2021

June 30, 2020

Changes

(dollars in thousands)

    

Amount

    

Percent

    

Amount

    

Percent

    

Amount

    

Percent

Net sales

    

$

3,412

    

100

%  

$

3,283

    

100

%  

$

129

4

%  

Cost of sales

 

2,579

 

76

%  

 

2,586

 

79

%  

 

(7)

%  

Gross profit

 

833

 

24

%  

 

697

 

21

%  

 

136

20

%  

Selling, general and administrative

 

733

 

21

%  

 

793

 

24

%  

 

(60)

(8)

%  

Operating income (loss)

 

100

 

3

%  

 

(96)

 

(3)

%  

 

196

204

%  

Other income, net

 

11

 

%  

 

1

 

%  

 

10

nm

%  

Interest expense

 

(30)

 

(1)

%  

 

(58)

 

(2)

%  

 

28

48

%  

PPP loan forgiveness

 

1,317

 

39

%  

 

 

%  

 

1,317

nm

%  

Income (loss) before taxes

 

1,398

 

41

%  

 

(153)

 

(5)

%  

 

1,551

nm

%  

Income tax provision (benefit)

 

27

 

1

%  

 

(37)

 

(1)

%  

 

64

173

%  

Net income (loss)

$

1,371

 

40

%  

$

(116)

 

(4)

%  

$

1,487

nm

%  


Net Sales

The Company records most of its revenue over time as it completes performance obligations. We measure progress for performance obligations satisfied over time using input methods (e.g., labor hours expended and time elapsed).

Net sales were $3.6 million for the three months ended December 31, 2020, or 3% lower when compared to net sales for the three months ended December 31, 2019 of $3.7 million. Net sales in our defense markets decreased by $0.3 million when compared to the three months ended December 31, 2019. However, our defense backlog remains strong as new orders for components continue to flow down from our prime defense contractors. Net sales to other commercial markets increased by $0.2 million when compared to the three months ended December 31, 2019, primarily on new projects for components built for a certain nuclear energy customer. We have experienced repeat business in these markets, but the order flow is uneven and difficult to forecast.

Cost of Sales and Gross Margin

Cost of sales consists primarily of raw materials, parts, labor, overhead and subcontracting costs. Cost of sales for the three months ended December 31, 2020 were $0.5 million lower when compared to the three months ended December 31, 2019, primarily because of the absence of any significant contract losses. The fiscal 2020 third quarter included a higher loss provision for certain customer projects.

As a result, gross profit was $0.7 million for the three months ended December 31, 2020, or $0.4 million higher when compared to the three months ended December 31, 2019. Gross margin was 19.8% for the three months ended December 31, 2020 and 8.6% for the three months ended December 31, 2019.

We continue to solve learning-curve challenges on a limited number of projects in the manufacturing schedule which had an unfavorable financial impact in fiscal 2020. Progress notwithstanding, until we complete and deliver the final units from these projects, they could have an unfavorable impact on gross margin in future quarterly periods.

Selling, General and Administrative Expenses

Total selling, general and administrative expenses for the three months ended December 31, 2020 increased by $54,172 compared to the three months ended December 31, 2019, due primarily to an increase in outside advisory services, which included expenses for the proposed Stadco acquisition.

Other Expense, net

Interest expense was lower for the three months ended December 31, 2020 when compared to the three months ended December 31, 2019, and should continue to be lower than the prior year, barring any additional borrowings for working capital purposes under our revolving credit facility, or any new credit facility to meet our changing capital resource needs. Debt issue costs increased as the Company began to amortize costs associated with increasing the borrowing limit under the Revolver loan with Berkshire bank and borrowings under the payroll protection program, or PPP. The following table reflects other income and expense, interest expense and amortization of debt issue costs for the three months ended:

  December 31, 2020  December 31, 2019  $ Change  % Change 
Other (expense) income, net $(219) $185  $(404)  (218)%
Interest expense $(36,391) $(58,817) $22,426   38%
Amortization of debt issue costs $(14,014) $(10,511) $(3,503)  (33)%

Income Taxes

For the three months ended December 31, 2020 and December 31, 2019, we recorded a tax benefit of $13,369 and $97,734, respectively. The tax benefit was the result of an operating loss.

Net Loss

As a result of the foregoing, for the three months ended December 31, 2020, we recorded a net loss of $48,172, compared with a net loss of $319,770 for the three months ended December 31, 2019.


Nine Months Ended December 31, 2020 and 2019

The following table sets forth information from our condensed consolidated statements of operations and comprehensive (loss) income, in dollars and as a percentage of revenue:

  December 31, 2020  December 31, 2019  Changes 
(dollars in thousands) Amount  Percent  Amount  Percent  Amount  Percent 
Net sales $11,566   100% $11,075   100% $491   4%
Cost of sales  9,035   78%  9,238   83%  (203)  (2)%
Gross profit  2,531   22%  1,837   17%  694   38%
Selling, general and administrative  2,206   19%  2,145   19%  61   3%
Income (loss) from operations  325   3%  (308)  (3)%  633   206%
Other expense, net  (159)  (1)%  (197)  (2)%  38   20%
Income (loss) before taxes  166   2%  (505)  (5)%  671   133%
Income tax expense (benefit)  60   1%  (115)  (1)%  175   152%
Net income (loss) $106   1% $(390)  (4)% $496   127%

nm - not meaningful

Net Sales

The Company records most of its revenue over time as it completes performance obligations. We measure progress for performance obligations satisfied over time using input methods (e.g., labor hours expended and time elapsed).

Changes in net sales generally reflect a different product mix and project volume when comparing the current and prior year periods. Net sales were 4% higher$3.4 million for the ninethree months ended December 31, 2020June 30, 2021, or 4% higher when compared to net sales for the ninethree months ended December 31, 2019.June 30, 2020. For the ninethree months ended December 31, 2020,June 30, 2021, net sales in our defense markets decreased by $0.4$0.1 million or 3% when compared to the ninethree months ended December 31, 2019. However, ourJune 30, 2020. Our defense backlog remains strong as new orders for components, including the U.S Navy submarine programs, continue to flow down from our prime defense contractors. contractors as these submarine-building programs accelerate.

Net sales to other commercialindustrial markets increased by $0.9$0.2 million when compared to the ninethree months ended December 31, 2019 on projects completed for customers in the nuclear energy and medical markets.June 30, 2020, due primarily to a higher level of project volume. We have experienced repeat business in this sector, but the order flow can be uneven and difficult to forecast.

For the three months ended June 30, 2021, revenue recognized over time was $3.1 million, an increase of 3% when compared to the three months ended June 30, 2020. Fiscal 2022 first quarter revenue recognized over time was generated by a favorable project mix with profitable gross margins.

19

Table of Contents

Remaining performance obligations reflect future revenue that will be recorded in subsequent periods as projects in progress are completed. At June 30, 2021 the Company had a backlog of $17.6 million, compared with a backlog of $18.6 million at March 31, 2021.

Cost of Sales and Gross Margin

 

Cost of sales consists primarily of raw materials, parts, labor, overhead and subcontracting costs. Our cost of sales for the ninethree months ended December 31, 2020 were $0.2June 30, 2021 was $2.6 million, slightly lower when compared to the ninethree months ended December 31, 2019, primarily onJune 30, 2020.

Project throughput was better for the absence of any significant contract losses. The fiscal 2020 nine month periodthree months ended June 30, 2021 than the same quarter a year ago. Decreases in labor costs and factory overhead, more than offset higher material costs for the three months ended June 30, 2021.

Gross margin was marked by new project startup activities24.2% for the three months ended June 30, 2021 and higher provisions21.2% for contract losses.

the three months ended June 30, 2020. Gross profit was $2.5$0.8 million for the ninethree months ended December 31, 2020,June 30, 2021, or 38%20% higher when compared to the ninethree months ended December 31, 2019. Gross margin was 21.9% forJune 30, 2020, the nine months ended December 31, 2020result of higher revenue and 16.6% for the nine months ended December 31, 2019.

lower cost of sales.

Selling, General and Administrative Expenses

Total selling, general and administrative expenses for the ninethree months ended December 31, 2020 increasedJune 30, 2021 decreased by $60,684 as$60,754 due to lower compensation and benefit costs, and lower spending for outside advisory services. These decreases more than offset an increase in compensationtravel and office costs more than offset a decreaseas coronavirus travel restrictions began to subside in travel expenses when compared to the nine months ended December 31, 2019.

first quarter of fiscal 2022.

Other Expense, net

Interest expense was lower for the nine months ended December 31, 2020 when compared to the nine months ended December 31, 2019, and should continue to be lower than the prior year, barring any additional borrowings for working capital purposes under our revolving credit facility, or any new credit facility to meet our changing capital resource needs. Debt issue costs increased as we began to amortize costs associated with amendments to the existing Berkshire loan agreement bank and new borrowings under the payroll protection program, or PPP.

Other income for the nine months ended December 31, 2019 included proceeds from the sale of machinery and equipment of $16,000. The following table reflects other income, interest expense, and amortization of debt issue costs and other income, net for the ninethree months ended:

    

June 30, 2021

    

June 30, 2020

    

$Change

    

% Change

 

Other income, net

$

10,390

$

652

$

9,738

 

nm

Interest expense

$

(21,054)

$

(42,757)

$

21,703

 

51

%

Amortization of debt issue costs

$

(8,824)

$

(15,141)

$

6,317

 

42

%

nm – not meaningful

  December 31, 2020  December 31, 2019  $ Change  % Change 
Other income, net $1,237  $21,063  $(19,826)  (94)%
Interest expense $(114,786) $(187,167) $72,381   39%
Amortization of debt issue costs $(45,099) $(31,280) $(13,819)  (44)%

Interest expense and amortized debt issue costs were lower for the three months ended June 30, 2021, due to lower levels of debt, when compared to the three months ended June 30, 2020. The interest expense line includes a reversal of accrued interest of $11,692 for the PPP loan, which was forgiven in May 2021. Also, the three months ended June 30, 2020 included $6,664 of interest expense for borrowings under the revolver loan. There were no amounts outstanding under the revolver loan during the three months ended June 30, 2021. Other income for the three months ended June 30, 2021 includes a return of $10,000 for a retainer fee previously paid for outside advisory fees in connection with a class action settlement in March 2021.


PPP Loan Forgiveness

On May 12, 2021, as authorized by Section 1106 of the CARES Act, the SBA remitted to Berkshire Bank, the lender of record, a payment of principal in the amount of $1,317,100, for forgiveness of the Company’s PPP loan. The funds credited to the PPP loan paid this loan off in full.

Income Taxes

For the ninethree months ended December 31, 2020June 30, 2021 we recorded a tax expenseprovision of $60,573 and$26,580, compared to a tax benefit of $115,092$37,360 for the ninethree months ended December 31, 2019. The tax benefit forJune 30, 2020. This resulted from our generation of net income during the ninethree months ended December 31, 2019 wasJune 30, 2021, compared to a net loss during the resultthree months ended June 30, 2020.

20

Table of an operating loss.Contents

The valuation allowance on deferred tax assets at December 31, 2020 was approximately $1.7 million. We believe that it is more likely than not that the benefit from certain state and foreign NOL carryforwards and other deferred tax assets will not be realized. In recognition of this risk, we continue to provide a valuation allowance on these items. In the event future taxable income is below management’s estimates or is generated in tax jurisdictions different than projected, the Company could be required to increase the valuation allowance for deferred tax assets. This would result in an increase in the Company’s effective tax rate.

Net Income (Loss)

As a result of the foregoing, for the ninethree months ended December 31, 2020,June 30, 2021, we recorded net income of $0.1$1.4 million compared withto a net loss of $0.4$0.1 million for the ninethree months ended December 31, 2019.

June 30, 2020.

Liquidity and Capital Resources

Small Business Administration Loan

On May 8, 2020, the Company, through Ranor, issued a promissory note, or the Note, evidencing an unsecured loan in the amount of $1,317,100 made to Ranor under the Paycheck Protection Program, or the PPP. The PPP was established under the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, and is administered by the U.S. Small Business Administration, or the SBA. The loan to Ranor was made through Berkshire Bank.

The Note provides for an interest rate of 1.00% per year and matures two years after the issuance date. Principal and accrued interest are payable monthly in equal installments commencing on the date that is approximately six months after the date funds are first disbursed on the loan and continuing through the maturity date, unless the Note is forgiven as described below. To be available for loan forgiveness, the Note may only be used for payroll costs, costs related to certain group health care benefits and insurance premiums, rent payments, utility payments, mortgage interest payments and interest payments on any other debt obligation that existed before February 15, 2020. The Note may be prepaid at any time prior to maturity with no prepayment penalties and contains events of default and other conditions customary for a Note of this type.

Under the terms of the CARES Act, PPP loan recipients can apply for and be granted forgiveness for all or a portion of loan granted under the PPP, with such forgiveness to be determined, subject to limitations, based on the use of the loan proceeds for payment of payroll costs, certain group health care benefits and insurance premiums, and any payments of mortgage interest, rent, and utilities. The terms of any forgiveness may also be subject to further requirements in any regulations and guidelines the SBA may adopt. While the Company currently believes that its use of the Note proceeds will meet the conditions for forgiveness under the PPP, no assurance is provided that the Company will obtain forgiveness of the Note in whole or in part.

On June 5, 2020, the PPP was amended to give borrowers more time to spend loan proceeds and still obtain loan forgiveness. The amendments extended the length of the covered period as defined in the CARES Act from eight to twenty-four weeks, while allowing borrowers that received PPP loans before June 5, 2020 to elect to use the original eight-week covered period. In addition, the amendments provide that if the borrower does not apply for forgiveness of a loan within ten months after the last day of the covered period, the PPP loan is no longer deferred and the borrower must begin paying principal and interest. As provided under the amendments, our first payment, if required, would not be due until September 11, 2021.

Berkshire Term Loan Facility

On December 21, 2016, TechPrecision, through Ranor, closed on a Loan Agreement with Berkshire Bank. Pursuant to the Berkshire Loan Agreement, Berkshire Bank made a term loan to Ranor in the amount of $2,850,000, and made available to Ranor a revolving line of credit of $1,000,000 under the Revolver Loan. The debt matures on December 20, 2021, with a balloon payment of approximately $2.4 million due under the terms of the Term Loan with Berkshire bank. We anticipate that we will be able to refinance that debt with Berkshire Bank.

On December 23, 2019, TechPrecision, through Ranor, entered into a Third Modification to Loan Agreement, and an Amended and Restated Promissory Note with Berkshire Bank. Under the Third Modification, Ranor and Berkshire agreed to increase the maximum principal amount available under the Revolver Loan from $1,000,000 to $3,000,000.

The Company borrowed $1.0 million under the Revolver Loan on April 3, 2020 and repaid that principal onAt June 30, 2020. There were no borrowed amounts outstanding under the Revolver Loan at December 31, 2020 and March 31, 2020. Interest-only payments on advances made under the Revolver Loan during the nine months ended December 31, 2020 totaled $6,664 at a weighted average interest rate of 2.67%.


On December 18, 2020, under the Fourth Modification, Ranor and Berkshire Bank agreed to revise the minimum interest rate payable on the Revolver Loan. Under the Line of Credit Note, the Company can elect to pay interest at an adjusted LIBOR-based rate or an Adjusted Prime Rate. Under the Fourth Modification, the minimum adjusted LIBOR-based rate is 2.75% and the Adjusted Prime Rate is the greater of (i) the Prime Rate minus 70 basis points or (ii) 2.75%. Interest-only payments on advances made under the Revolver Loan will continue to be payable monthly in arrears. The maturity date of the Revolver Loan was also extended to December 20, 2022. All other material terms of the Loan Agreement and Line of Credit Note were unchanged. Unused borrowing capacity at December 31, 2020 was $3.0 million.

At December 31, 2020,2021, we had cash and cash equivalents of $1.3$2.2 million and working capital of $4.2$5.5 million. We believe our available cash plus cash expected to be provided by operations during fiscal 2021,2022, and borrowing capacity available under the Revolver Loanrevolver loan will be sufficient to fund our operations,expected capital expenditures for our business as it exists today and principal and interest payments under our debt obligations through the 12 months from the issuance date of our financial statements. However, following the closing of the potential acquisition of Stadco, or in connection therewith, we may need to reevaluateexpect our financing needs to increase in light of the significant changes we expect to the combined company’sCompany’s capital resource needs. As a result, we may decideexpect to seek new debt and/or equity financing.

There were no borrowed amounts outstanding under the revolver loan at June 30, 2021 and March 31, 2021. Unused borrowing capacity at June 30, 2021 was $3.0 million. The maturity date of the revolver loan is December 20, 2022.

The Company intends to refinance the term loan with Berkshire Bank. There is a balloon payment of $2.4 million due on December 20, 2021 under the term loan with Berkshire Bank. We expect to refinance this debt with the bank before the maturity date. Until then, the Company will continue to pay down principal and make interest payments in the ordinary course.

The table below presents selected liquidity and capital measures atfor the indicated dates:period ended:

    

    

    

Change 

(dollars in thousands) 

December 31,

2020

  

March 31,

2020

  

Change

Amount

 

June 30, 2021

March 31, 2021

Amount

Cash and cash equivalents $1,255  $931  $324 

$

2,236

$

2,131

$

105

Working capital $4,170  $5,595  $(1,425)

$

5,501

$

5,202

$

299

Total debt $3,823  $2,587  $1,236 

$

2,485

$

3,829

$

(1,344)

Total stockholders’ equity $9,694  $9,469  $225 

$

11,346

$

9,942

$

1,404

The following table summarizes the primary components of cash flows for the ninethree months ended:

    

    

    

Change

(dollars in thousands) 

December 31,

2020

  

December 31,

2019

  

Change

Amount

 

June 30, 2021

June 30, 2020

 Amount

Cash flows provided by (used in):            

 

  

 

  

 

  

Operating activities $(340) $609  $(949)

$

137

$

(369)

$

506

Investing activities  (547)  (35)  (512)

 

(4)

 

(42)

 

38

Financing activities  1,211   (642)  1,853 

 

(27)

 

1,282

 

(1,309)

Net increase (decrease) in cash $324  $(68) $392 

Net increase in cash and cash equivalents

$

106

$

871

$

(765)

Operating activities

Our primary sources of cash are from accounts receivable collections, customer advance payments and project progress payments. Our customers make advance payments and progress payments under the terms of each manufacturing contract. Our cash flows can fluctuate significantly from period to period as the composition of our receivables collections mix changes between advance payments progress payments and customer payments made after shipment of finished goods. Cash used inprovided by operations for the ninethree months ended December 31, 2020June 30, 2021 was $0.3$0.1 million compared with cash provided byused in operations of $0.6$0.4 million for the three months ended June 30, 2020. Cash outlays for the three months ended June 30, 2021 includes a payment of $0.5 million to plaintiffs for a court approved final class action settlement.

The first quarter of fiscal 2020.

We used2022 was marked by favorable project performance progress and delivery schedules which generated higher amounts of cash, in operations duringcompared to the same quarter of fiscal 2021. During our first nine monthsquarter of fiscal 2021 as accounts receivable and contract assets increased and contract liabilities decreased due to a changing production mix. We have we

21

Table of Contents

encountered some delayed inspections, delayed deliveries, and disrupted supply chain, issues, due to travel restrictions in connection with the COVID-19 pandemic. The future financial impactIn addition, we expended more direct labor hours on low margin projects. All of these events resulted in a slower payment flow from customers during the COVID-19 pandemic cannot be reasonably estimated at this time as its impact depends on future developments, which are highly uncertain and cannot be predicted.first quarter of fiscal 2021.

Investing activities

We do not anticipate any additional expenditures forthat we will spend approximately $1.1 million in new factory machinery and equipment for Ranor during the last quarterremainder of fiscal 2021.2022. Net cash used in investing activities for purchases of property, plant and equipment in the ninethree months ended December 31,June 30, 2021 and 2020 was $4,198 and 2019 totaled $546,890 and $35,225,$41,768, respectively. The increase in

Financing activities

For the ninethree months ended December 31,June 30, 2021 and 2020, occurred because the Company purchased new robotic equipment during fiscal 2021.


Financing activities

we made paid down debt principal of $27,166 and $26,618 for our term debt and finance lease obligations.

On May 8, 2020 we borrowed $1.3 million under the CARES Act payroll protection program. On April 3, 2020 we borrowed $1.0 million under our RevolverPPP. This PPP loan then paid down $1.0 million in principalwas forgiven by the SBA on June 30, 2020.

For the nine months ended December 31, 2020 and 2019 we made monthly principal payments of $81,352 and $610,515 in connection with our term debt and finance lease obligations.

May 12, 2021.

All of the above activity resulted in a net increase in cash of $0.3 million for the nine months ended December 31, 2020 compared with a decrease in cash of $0.1 million for the ninethree months ended December 31, 2019.June 30, 2021 compared with a net increase in cash of $0.9 million for the three months ended June 30, 2020.

Small Business Administration PPP Loan

On May 8, 2020, the Company, through its wholly owned subsidiary Ranor, Inc., issued a promissory note evidencing an unsecured PPP loan in the amount of $1,317,100 made to Ranor under the CARES Act. The PPP loan to Ranor was made through Berkshire Bank.

Under the terms of the CARES Act, PPP loan recipients can apply for and be granted forgiveness for all or a portion of loans granted under the PPP, with such forgiveness to be determined, subject to limitations, based on the use of the loan proceeds for payment of payroll costs, certain group health care benefits and insurance premiums, and any payments of mortgage interest, rent, and utilities.

The Company applied for loan forgiveness with the SBA under the Paycheck Protection Program on March 26, 2021. On May 12, 2021, as authorized by Section 1106 of the CARES Act, the SBA remitted to Berkshire Bank, the lender of record, a payment of principal and interest in the amount of $1,317,100 and $13,207, respectively, for forgiveness of the Company’s PPP loan. The funds credited to the PPP loan paid this loan off in full. Loan forgiveness is recorded as a gain under other income and expense in the condensed consolidated statement of operations.

Off-Balance Sheet Arrangements

We do not currently have, and have not had, any off-balance sheet assets, liabilities or arrangements at December 31, 2020.

June 30, 2021.

EBITDA Non-GAAP Financial Measure

To complement our condensed consolidated statements of operations and comprehensive income (loss) income and condensed consolidated statements of cash flows, we use EBITDA, a non-GAAP financial measure. Net income (loss) income is the financial measure calculated and presented in accordance with U.S. GAAP that is most directly comparable to EBITDA. We believe EBITDA provides our board of directors, management and investors with a helpful measure for comparing our operating performance with the performance of other companies that have different financing and capital structures or tax rates. We also believe that EBITDA is a measure frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry, and is a measure contained in our debt covenants. However, while we consider EBITDA to be an important measure of operating performance, EBITDA and other non-GAAP financial measures have limitations, and investors should not consider them in isolation or as a substitute for analysis of our results as reported under GAAP.

22

Table of Contents

We define EBITDA as net income (loss) income plus interest, income taxes, depreciation and amortization. Net income was $1.4 million for the three months ended June 30, 2021, as compared to net loss of $0.1 million for the three months ended June 30, 2020. EBITDA, a non-GAAP financial measure, was $0.8$1.6 million for the ninethree months ended December 31, 2020,June 30, 2021, as compared to $0.3$0.1 million for the ninethree months ended December 31, 2019.June 30, 2020. The following table provides a reconciliation of EBITDA to net income (loss) income,, the most directly comparable GAAP measure reported in our condensed consolidated financial statements for the following periods:three months ended:

 Three Months ended December 31,  Nine Months ended December 31, 

    

    

    

Change 

(dollars in thousands) 2020  2019  Change  2020  2019  Change 

June 30, 2021

June 30, 2020

Amount

Net (loss) income $(48) $(320) $272  $106  $(390) $496 
Income tax (benefit) expense  (13)  (98)  85   61   (115)  176 

Net income (loss)

$

1,371

$

(116)

$

1,487

Income tax provision (benefit)

 

27

 

(37)

 

64

Interest expense (1)  50   69   (19)  160   218   (58)

 

30

 

58

 

(28)

Depreciation and amortization  182   168   14   521   548   (27)

Depreciation

 

183

 

169

 

14

EBITDA $171  $(181) $352  $848  $261  $587 

$

1,611

$

74

$

1,537

(1) Includes amortization of debt issue costs.

Item 3.

Item 3.Quantitative and Qualitative Disclosure About Market Risk.

As a smaller reporting company, we have elected not to provide the information required by this Item.

Item 4.

Item 4.Controls and Procedures.

Evaluation of Disclosure Controls and Procedures.

Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are controls and procedures that are designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and includes controls and procedures designed to ensure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

As of the end of the period covered by this report, an evaluation was carried out, under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of December 31, 2020,June 30, 2021, our disclosure controls and procedures were effective at a reasonable assurance level.


Inherent Limitations Over Internal Controls

The Company’s internal control over financial reporting is designed under the supervision of our Chief Executive Officer and Chief Financial Officer, and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP. The Company’s internal control over financial reporting includes those policies and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company’s assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that the Company’s receipts and expenditures are being made only in accordance with authorizations of the Company’s management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

Management, including the Chief Executive Officer and Chief Financial Officer, does not expect that the Company’s internal controls will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered

23

Table of Contents

relative to their costs. Because of the inherent limitations in all control systems, no evaluation of internal controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Also, any evaluation of the effectiveness of controls in future periods is subject to the risk that those internal controls may become inadequate because of changes in business conditions, or that the degree of compliance with the policies or procedures may deteriorate.

Changes in Internal Control over Financial Reporting

For the quarter ended December 31, 2020,June 30, 2021, there have been no changes in our internal control over financial reporting that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

24

Table of Contents

PART II. Other Information.

Item 6.Exhibits.

Exhibit Index

Item 1A.
Risk Factors

Our ability to complete the acquisition of Stadco is subject to closing conditions, including the receipt of consents and approvals from third parties, which may impose conditions that could adversely affect us or cause the acquisition not to be completed.

Our acquisition of Stadco and its affiliates is subject to a number of closing conditions as specified in the stock purchase agreement entered into with Stadco and its holding company. These include, among others, the entry into arrangements with certain lenders of Stadco and its affiliates and the absence of governmental restraints or prohibitions preventing the consummation of the acquisition. No assurance can be given that the required consents and approvals will be obtained or that the closing conditions will be satisfied in a timely manner or at all. Any delay in completing the acquisition could cause the combined company not to realize, or to be delayed in realizing, some or all of the benefits that we expect to achieve. In addition, we can provide no assurance that these conditions will not result in the abandonment or delay of the acquisition. The occurrence of any of these events could have a material adverse effect on our results of operations, cash flows, financial condition and/or the trading price of our common stock.

We may not achieve the intended benefits of our acquisition of Stadco, and the acquisition may disrupt our current plans or operations.

We may not be able to successfully integrate Stadco’s business and assets or otherwise realize the expected benefits of the transaction, including anticipated annual operating cost and capital synergies to the extent currently anticipated, or at all. To realize these anticipated benefits, our business and Stadco’s business must be successfully combined, which is subject to our ability to consolidate operations, corporate cultures and systems and our ability to eliminate redundancies and costs. Difficulties in integrating Stadco into our operations may result in the combined company performing differently than expected, in operational challenges or in the failure to realize anticipated synergies and efficiencies in the expected time frame or at all. The integration of the two companies may result in material challenges, including the diversion of management’s attention from ongoing business concerns; retaining key management and other employees; retaining existing business and operational relationships, including customers and other counterparties, and attracting new business and operational relationships; the possibility of faulty assumptions underlying expectations regarding the integration process and associated expenses; consolidating corporate and administrative infrastructures and eliminating duplicative operations; coordinating geographically separate organizations; difficulties in the assimilation of employees and corporate cultures; unanticipated issues in integrating information technology, communications and other systems; as well as unforeseen expenses or delays associated with the acquisition. If we are not successful in integrating Stadco’s business and assets or otherwise fail to realize the expected operating efficiencies, cost savings and other benefits currently anticipated from the Stadco acquisition, our results of operations, cash flows and financial condition may be materially adversely affected.


Whether or not it is completed, the announcement and pendency of the acquisition of Stadco could cause disruptions in our business, which could have an adverse effect on our business and financial results.

Whether or not it is completed, the announcement and pendency of our acquisition of Stadco could cause disruptions in our business: our and Stadco’s current and prospective employees may experience uncertainty about their future roles with the combined company, which might adversely affect the ability to retain key employees; uncertainty regarding the completion of the acquisition may cause customers, suppliers, distributors, vendors, strategic partners or others to delay or defer entering into contracts, make other decisions or seek to change or cancel existing business relationships; and the attention of management may be directed toward the completion of the acquisition. If the acquisition is not completed, we will have incurred significant costs and diverted management resources, for which we will have received little or no benefit.

We are expected to incur substantial expenses related to the acquisition of Stadco and its affiliates and the integration of their business with ours.

We expect to incur substantial expenses in connection with the integration of our business with Stadco and its affiliates. There are a large number of processes, policies, procedures, operations, technologies and systems that must be integrated, including purchasing, accounting and finance, sales, payroll, pricing, revenue management, marketing and benefits. In addition, our and Stadco’s businesses will continue to maintain a presence in Westminster, Massachusetts and Los Angeles, California, respectively. Some of these costs will be non-recurring expenses related to the acquisition itself, including legal and accounting costs and systems consolidation costs. We may also incur additional costs to attract, motivate or retain management personnel and other key employees. We have incurred and will continue to incur acquisition fees and costs related to formulating integration plans for the combined business, and the execution of these plans may lead to additional unanticipated costs.

Our stockholders may not realize a benefit from the acquisition of Stadco commensurate with the ownership dilution they will experience in connection with the transaction.

If the combined company is unable to realize the full strategic and financial benefits currently anticipated from the acquisition of Stadco and its affiliates, our stockholders will have experienced substantial dilution of their ownership interests without receiving any commensurate benefit, or only receiving part of the commensurate benefit to the extent the combined company is able to realize only part of the strategic and financial benefits currently anticipated from the acquisition.

The market price of our common stock following the acquisition of Stadco may decline as a result of the transaction.

The market price of our common stock may decline as a result of our acquisition of Stadco and its affiliates for a number of reasons, including if:

·investors react negatively to the prospects of the combined company’s business and financial condition following the acquisition;

·the effect of the acquisition on the combined company’s business and prospects is not consistent with the expectations of financial or industry analysts; or

·the combined company does not achieve the perceived benefits of the acquisition as rapidly or to the extent anticipated by management and the Company’s investors, or at all.


Item 6. Exhibits.

Exhibit IndexNo.

Description

Exhibit No.

2.1

Description

2.1*

Third Amendment to Stock Purchase Agreement, dated as of July 20, 2021, among TechPrecision Corporation, Stadco New Acquisition, LLC, Stadco,STADCO, Stadco Acquisition, LLC and the stockholders of Stadco, datedDouglas A. Paletz, as of October 16, 2020stockholders’ representative (incorporated herein by reference to Exhibit 2.1 to our Current Report on Form 8-K filed with the Commission on October 20, 2020)July 26, 2021).

3.1

3.1

Certificate of Incorporation of the Registrant (incorporated herein by reference to Exhibit 3.1 to our registration statement on Form SB-2, filed with the Commission on August 28, 2006).

3.2

3.2

Amended and Restated By-laws of the Registrant (incorporated herein by reference to Exhibit 3.1 to our Current Report on Form 8-K, filed with the Commission on February 3, 2014).

3.3

3.3

Certificate of Designation for Series A Convertible Preferred Stock of the Registrant (incorporated herein by reference to Exhibit 3.1 to our Current Report on Form 8-K, filed with the Commission on March 3, 2006).

3.4

3.4

Certificate of Amendment to Certificate of Designation for Series A Convertible Preferred Stock of the Registrant (incorporated herein by reference to Exhibit 3.5 to our Quarterly Report on Form 10-Q, filed with the Commission on November 12, 2009).

10.1

10.1*

Fourth Modification to Loan Agreement and First Modification and Allonge to Amended and Restated Promissory Note,Loan Purchase and Sales Agreement, dated December 18, 2020,as of April 23, 2021, between Ranor, Inc.Stadco New Acquisition, LLC and BerkshireSunflower Bank, N.A. (incorporated herein by reference to Exhibit 10.1 to our Current Report,Form 8-K filed with the Commission on December 21, 2020)April 29, 2021).

10.2

Amendment to Amended and Restated Loan Purchase and Sale Agreement, dated as of June 28, 2021, between Stadco New Acquisition, LLC, Stadco, Stadco Acquisition LLC and Stadco Mexico, Inc. and Sunflower Bank, N.A. (incorporated herein by reference to Exhibit 10.1 to Form 8-K filed with the Commission on June 29, 2021).

31.1

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

31.2

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

32.1

Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101.INS

XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.

101

101.SCH

XBRL Taxonomy Extension Schema Document

101.CAL

XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

XBRL Taxonomy Extension Label Linkbase Document

101.PRE

XBRL Taxonomy Extension Presentation Linkbase Document

104

Cover Page Interactive Data File - The following financial information from this Quarterly Report on Form 10-Q forcover page interactive data file does not appear in the three and nine months ended December 31, 2020, formatted inInteractive Data File because its XBRL (Extensible Business Reporting Language): (i)tags are embedded within the Condensed Consolidated Balance Sheets at December 31, 2020 and March 31, 2020; (ii) the Condensed Consolidated Statements of Operations and Comprehensive Income for the three and nine months ended December 31, 2020 and 2019; (iii) the Condensed Consolidated Statements of Stockholders’ Equity for the periods ended December 31, 2020 and 2019; (iv) the Condensed Consolidated Statements of Cash Flows for the nine months  ended December 31, 2020 and 2019; and (v) the Notes to the Condensed Consolidated Financial Statements.Inline XBRL document

*Pursuant to Item 601(a)(5)

25

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

TechPrecision Corporation

August 12, 2021

By: 

February 11, 2021By: 

/s/ Thomas Sammons

Thomas Sammons

Chief Financial Officer


26